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INTRODUCTION History of headache Headache had been a mankind troubler since the
rise of civilization. Neolithic human skulls dating 3000-7000 BC (1) were discovered
with signs of perforation with an instrument known as TREPANATION, performed
originally to release demons and evil spirits but recently evident to be carried out for
medical reasons2 TREPANATION still practiced in African tribes for headache relief
and fracture line removal following head injury(3). In ancient Egypt Headache
prescriptions were written on papyrus. The Eber papyrus dated circa 1200 BC describes
migraine, neuralgia and shooting pains(4)in medical documents from 2500 BC.
Compression and cooling the scalp (5) method...
ABSTRACT 
 
Aim- To study about clinical evaluation of headache, its management and about effectiveness of 
radiological investigations to find out type of headache. 
Study Design-Prospective Clinical Study 
Methodology- Patients presenting with headache for more than 1 month of all age groups and sexes 
were selected. Selected patients were subjected to detailed history  and complete examination according 
to a defined proforma. According to clinical diagnosis,radiological investigations are done.Patients with 
Migraine and Tension headache features were consulted with neurologist and psychiatrist.Treatment is 
given accordingly. 
Results-Most common type of headache is Tension headache. Majority of the patients were of age group 
21-50 years and it is more predominant in males. Next Most common type of headache is migraine. It’s 
is more common in females in 1:2 ratio. Third common type of headache is sinus headache and it is 
more predominant in males. Headache was localized more than one site (59%) in majority of cases 
and 22% in forehead region. Patients who were having mucosal contact points headache, underwent 
FESS and 88.89% of patients were relieved from headache. T.Propranalol 80 mgs and Amitriptyline 50 
mgs were given for migraine patients. Most of the patients had subjective relief of headache. Patients 
diagnosed with tension headache were treated with relaxation techniques, physical exercises and 
Amitriptyline 10 mgs once a day in evening and most of the patients had subjective relief of headache. 
Conclusion- Headache is nearly a universal human experience. The lifetime incidence of headache 
is estimated to be at least 90%. A carefully taken history is key to accurate diagnosis and the 
majority of patients will not have sinogenic pain. Accurate diagnosis will be helpful for 
successful treatment. 
Key Words- Tension headache, Migraine, Sinusitis, FESS 
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A STUDY OF EVALUATION AND
MANAGEMENT OF PATIENTS
WITH
HEADACHE
INTRODUCTION
History of headache-
Headache had been a mankind troubler since the rise of civilization.
Neolithic human skulls dating 3000-7000 BC(1) were discovered with signs of
perforation with an instrument known as TREPANATION, performed originally to
release demons and evil spirits but recently evident to be carried out for medical
reasons2 TREPANATION still practiced in African tribes for headache relief and
fracture line removal following head injury(3).
In ancient Egypt Headache prescriptions were written on papyrus.
The Eber papyrus dated circa 1200 BC describes migraine, neuralgia and shooting
pains(4) in medical documents from 2500 BC.  Compression and cooling the scalp (5)
method using strip of linen with clay and grains (5,6) were practiced then for
headache relief.
Hippocrates 470-410 BC described headache as a shining light in
the right eye with violent pain arising in the temples and spreading to the entire head
and neck area being triggered by exercise and intercourse(6) and relieved by
vomiting.Aretaeus in second century AD discovered migraine headache based on
descriptions of migraine by Celsus 215-300 AD .Galen in 200 AD introduced the
term ‘migraine’ from greek word ‘hemicrania’.Abbess Hildegrade of Bingen in 12 th
century described in terms of migraine aura. Thomas Williams in 1683 described
prodromal symptoms associated with migrainous headache.Tissot in 1783(8)
differentiated migraine from common headaches stating it to be a supraorbital
neuralgia Dubois Raymond,Mollendorf and Eulenberg put forth different vascular
theories for migraine(7).
Erasmus Darwin in 18th century believed headache caused by
vasodilatation could be treated by centrifugation. In 1778, Fothergill termed
migrainous aura as ‘fortification spectra’(9,10).Liveing in 1873 originated the neural
theory of migraine in the first monograph entitled On Megrim,Sick-headache,and
Some Allied Disorders: A Contribution to the Pathology of Nerve storms William
Gowers in 1888 in his neurology textbook, A Manual of the Diseases of the Nervous
system recommended  lifestyle modifications and use of Gower’s mixture
[nitroglycerin 1% alcohol solution] and marijuana  for treating headaches.
In the line of treatment of migraine, Ergot being the mainstay ,the
history accounts since the middle ages in greek and roman ancient writings.
Epidemics of ergot poisoning broke out with the disease known as ‘Ignis sacer’ or
‘Holy Fire” or ‘St. Anthony’s Fire’. The term ‘ERGOT’ is derived from French
word ‘argot’ meaning ‘rooster spur ‘describing the small banana shaped sclerotium
(11) of the fungus.Louis Rene Tulasne of Paris in 1853 established that ergot is a
fungus named ‘Claviceps purpurea’with three stages in one life cycleHeinrich
Wiggers in 1831 tested ergot in animal models and studied the physiological
properties of ergot by the ‘rooster comb test’.Woakes in 1868 reported the use of
ergot of rye in neuralgia (12) treatment.
Eulenberg  of Germany in 1883 ,Thomson of  United states in
1894 ,Campbell of England in 1894 and Stevens in 1907(13) reported the use of ergot
for migraine early in the history of medical literature. Stoll in 1918 isolated the first
pure ergot alkaloid,ERGOTAMINE,used mainly in obstetrics and gynaecology until
1925.Rothlin used subcutaneous ergotamine tartrate, a vasoconstrictor to treat
intractable migraine successfully for the first time. John Graham and Harold Wolff
(14) in 1938 proved the vascular theory of migraine stating ergotamine to be a
vasoconstrictor.
The modern approach treating headaches began with the
development of TRIPTANS by Humprey and his colleagues(15) with the belief that
migraine  is due to excess serotonin. Sicuteri(16) developed methylsergide ,a
serotonin antagonist for migraine and cluster headache  prophylaxis.Currently many
newer drugs are being tested and developed  with concomitant development in basic
sciences and the renewed dedication of the clinicians in diagnosis and treatment of
headache  .
Pain in the head, face, throat, and upper neck is a major cause of
care seeking that leads to a primary or secondary referral to otolaryngology. The
dramatic advances in epidemiology, diagnosis, diagnostic testing, and treatment of
headache have made case finding more satisfying. Evidence-based medicine has
presented challenges to long-held beliefs. The most important of these is the
recognition that migraine underlies most of the common headaches in clinical
practice, including sinus headache. Improvements in diagnosis and treatment have
begun to affect care delivery and patient satisfaction. The International
Classification of Headache Disorders, 2nd edition (17) divides the head and face
pains into primary or secondary disorders. The primary headaches include
migraine, tension type, trigeminal autonomic cephalalgias, and other primary
headaches, including common or unusual but benign headaches.Secondary
headache results from either pathology of the head and its surrounding structures
or from systemic disease and effects on cranial nociception. The task of the
practicing specialist is to differentiate those headaches requiring urgent attention
from the more benign primary headaches.
AIMSANDOBJECTIVES
• To study about clinical evaluation of headache
• To study about effectiveness of radiological investigations to find out type of
headache
• To find out the effective management of each type of headache and comparison
with previous studies
• Latest trends in management of sinusitis
Anatomy and Pathobiology of Head and Face Pain
The parenchyma of the brain is insensitive to direct noxious
stimuli. The trigeminal nerve is the largest of all the cranial nerves. It is a mixed
nerve situated on the ventrolateral aspect of the pons. The sensory root conveys
impulses from the face and scalp, parts of the external ear and acoustic meatus, the
nasal and oral cavities, teeth, temporomandibular joint (TMJ), nasopharynx, and
most of the meninges of the anterior and middle fossa. It passes outward and
forward over the petrous temporal bone near the apex, extending into the
trigeminal ganglion. These pseudounipolar cells pass peripherally to become the
three major divisions: ophthalmic, maxillary, and mandibular.
The ophthalmic division is joined by projections of the internal
carotid sympathetic plexus and communicates with the oculomotor, trochlear, and
abducens nerves as it courses along the lateral wall of the cavernous sinus. The
main termination exits the skull through the superior orbital fissure. Other
branches include the tentorial, lacrimal, frontal, and maxillary nerves. The
maxillary division also carries sympathetic and parasympathetic fibers. Its
meningeal branch (middle cranial fossa) travels in the inferior part of the lateral
wall of the cavernous sinus to leave the skull through the foramen rotundum,
entering the pterygopalatine fossa where it communicates with the pterygopalatine
ganglion and enters the orbit through the inferior orbital fissure. The infraorbital
nerve then emerges on the face, where smaller branches (inferior palpebral,
external and internal nasal, and superior labial branches) supply the lower eyelid,
nasal alae, and upper lip. Additional branches go to the zygoma, upper teeth, and
gums as the superior alveolar and superior dental nerves. The mandibular nerve
exits through the foramen ovale to supply the meninges. It reenters the skull
through the foramen spinosum and travels along the middle meningeal artery to
supply the meninges of the middle and anterior cranial fossae, calvaria, and
mucous membranes of the mastoid air cells. The buccal nerve innervates the
mucous membranes and buccinator muscle. Other sensory branches of the
mandibular nerve include the auriculotemporal and lingual nerves, which
innervate the TMJ and tongue as well as the dental and mucosal surfaces of the
lower jaw.
In the primary head and face pains, abnormal activation of
peripheral neurons or central structures results in distinctive pain description,
phenomenology, and associations (18). These may then refer to areas of the head,
neck, or face at distance from the area of activation, making diagnosis more
challenging. The central connections of second-order sensory neurons of the
trigeminal system project to the thalamus and thence to the primary sensory cortex
of the parietal lobe. Descending inhibitory projections from periaqueductal gray
and paracentral aminergic nuclei modify the pain experience and have become
increasingly important in our understanding of the primary headaches.
Table 1-
INTRACRANIAL PAIN SENSITIVE STRUCTURES
Major arteries in brain base
Artery-Internal carotid, Ophthalmic artery
Vertebrobasilar system and major branches
Circle of Willis
Proximal segments of cerebral arteries
Major venous sinuses and adjacent major venous tributaries
Middle meningeal artery
Cranial nerves V, VII, IX, and X
Floor of the pituitary fossa
Upper three cervical nerves (pain referral to occiput)
Secondary headaches rarely are initially seen with distinctive pain
characteristics. Many secondary headaches mimic migraine, tension-type, cluster,
or short-duration headache. It is therefore necessary for the clinician to assess the
patient's history carefully for clues to diagnosis of more urgent or serious
headache. Some well-known examples of classical  presentations include
monocular eye pain with pupillary dysfunction in optic neuritis, sinus disease, or
jaw claudication in temporal arteritis.
First-division pain typically refers to the scalp or face anterior to
the coronal suture, although it can be felt deep inside the head or in the occiput.
Lesions in the middle fossa can refer to the apex of the head or in the midnasal
bridge, as can pain arising from the deep ethmoid or sphenoid sinuses or the sella
turcica. With lesions involving posterior fossa structures, pain is referred to the
back half of the head and upper neck. Pain coming from diffuse intracranial
disease, including meningitis, can mimic primary headache of the tension type, or
more severe diffuse head pain with meningismus.
Extracranial Patterns of Referral-
Orbital pathology usually is first seen with monocular pain and
often has associated visual disturbances. Unilateral eye pain should be considered
an ophthalmologic emergency. Sinus pathology has historically been associated
with distinctive patterns of referral. Disease in the frontal sinus may appear with
frontal pain or pain radiating behind the eyes or to the vertex. Maxillary pain is
typically infraorbital in location, and ethmoidal disease appears between and
behind the eyes or to the vertex, as does the sphenoid. In our experience,
mastoid disease may first be seen as unilateral occipital pain or with cluster-like
headache. Other mimics of cluster headache (CH) include carotid disease and
dissection. The TMJ and the muscles of mastication can be a source of pain that
radiates to the head and the ear. The TMJ and its articulations are innervated by
the auriculotemporal nerve as it passes behind the condyle and then upward in
front of the ear. Pain can be reported as a diffuse temporal headache or as
ipsilateral ear pain. Tooth pain is poorly localized and can be confused with
disorders occurring outside the mouth. It can appear as diffuse facial or ear pain.
Pulpal death results in localization of the pain to the offending tooth. Cervical
disease including spondylosis can be seen with unilateral head pain, sharing
features of migraine. Vascular structures of the anterior neck can cause pain that
radiates into the lower face. A clinically recognized complication of carotid
dissection is cluster-like headache and complete or incomplete Horner syndrome.
Headache Diagnosis and Testing-
A detailed history and physical examination are the keys to efficient
assessment of headache patients . Particular attention should be paid to pain
characteristics, including rate of onset, rate of offset, intensity, quality, location,
duration, and response to medications.
Pain localization may be helpful, although referral patterns are not
diagnostic of secondary headaches in general. Establishing the temporal profile,
including duration, is essential to good diagnosis. Exacerbating and relieving
factors and associated nonpainful symptoms should be noted. In primary care
practice, 94% of patients with recurrent headache have migraine or migrainous
headache (19). Migraine is most frequently misdiagnosed as sinus headache or
tension-type headache (20). In the emergency department, 95% of patients with a
headache have migraine (21). Recognized features of clinical history and physical
examination can alert the physician to underlying organic diseases of a more
serious nature.
Magnetic resonance imaging (MRI) is the gold-standard radiographic
study for headache diagnosis. Only 0.18% with migraine and a normal neurologic
examination will have significant pathology. Computed tomography (CT) is still
the test of choice for acute, thunderclap, or new-onset headache in the emergency
department to rule out hemorrhage. CT does miss multiple vascular malformations
including aneurysms; meningeal, pituitary, and intracranial neoplasm; Chiari
malformations; posterior fossa tumors and malformations; paranasal sinus disease;
encephalitis; meningitis; and cerebritis. Low or high cerebrospinal fluid (CSF)
pressure with headache and complications also may be missed with routine CT
scans. Electroencephalography (EEG) has minimal sensitivity for headache
diagnosis. Lumbar puncture is indicated for acute headache with a negative CT
and for chronic headache in which infection or pressure measurement is essential.
Table 2-
DIAGNOSIS HISTORY IN PATIENTS WITH HEADACHE
History of present illness
Age at onset, progression to the present
Frequency timing and duration of attacks
Quality of the pain, including severity
Associated symptoms including warning symptoms or aura
Precipitating and/or relieving factors including medications
Medical history
Prior surgery or trauma to head or neck Allergies, diabetes, hypertension,
psychiatric illness,      recurrent infections, Current medications including over-the-
counter analgesics, birth control pills, herbal medications, topical agents
Family and social history
Migraine, tension or sinus headache, psychiatric illness, substance abuse, suicide
Cerebrovascular or cardiovascular disease, especially young
Marital status and occupation
Stress factors
Tobacco, alcohol, and drug use
Review of systems
Changes in weight, appetite, sleep, mood, or somatic sensation including pain
and     limitations to activity or range of motion
Trauma including traumatic life events
Symptoms suggestive of endocrine disturbance
Table 3-
DIAGNOSIS CLINICAL FEATURES SUGGESTING SERIOUS CAUSE FOR
HEADACHE
Crescendo headache in any age group
Headaches exclusively triggered by cough or exertion
Early-morning headache
Vomiting without significant premonitory nausea
Projectile vomiting or persistent hiccoughing
Associated fever, stiff neck, lethargy, confusion
Associated seizures, syncope, diplopia, visual obscurations
Sudden-onset  of worst headache of my life,Known malignancy or chronic infection
including human immunodeficiency virus,Endocrine disturbance of any kind,Focal
neurologic symptoms or signs,Papilledema, visual field loss
Temporal artery tenderness, thickening
Classification
Understanding headache and facial pain is essential to facilitate
diagnosis and treatment. To this end, definitions and features of clinical syndromes
were organized by the Headache Society- International.
This classification, with inclusion of diagnostic criteria for headaches, cranial
neuralgias and facial pain, was created in 1988 and has facilitated the diagnostic
approach and management of craniofacial pain across many medical fields.
Table 4-
Headache Society Classification of Headache and Facial Pain
Migraine type
Without aura (common migraine)
With aura (classic migraine)
With prolonged aura (complicated migraine)
Ophthalmoplegic
Retinal
Tension type
Episodic (muscle contraction headache)
Chronic (chronic daily headache)
Oromandibular dysfunction (myofascial pain dysfunction syndrome)
(temporomandibular joint pain dysfunction syndrome)
Cluster (Horton’s cephalalgia)
Post-traumatic headache
Vascular intracranial disorder
Transient ischemic attack-associated headache
Haematoma -Intracranial
Haemorrhage -Subarachnoid
Acute arterial hypertension
Pheochromocytoma
Malignant hypertension (accelerated)
Pre-eclampsia and eclampsia
Non-vascular intracranial disorder
Pseudo tumor cerebri
Post-lumbar puncture headache
Cerebrospinal fluid fistula headache
Intracranial infection
Meningitis
Brain abscess
Subdural empyema
Intracranial neoplasm
Headache from substance exposure or withdrawal
Acute exposure
Nitrate or nitrite-induced headache (hotdog headache)
Monosodium glutamate-induced headache (Chinese restaurant syndrome)
Carbon monoxide-induced headache
Alcohol-induced headache
Chronic exposure
Ergotamine-induced headache
Analgesics abuse headache
Oral contraceptives use
Acute withdrawal
Alcohol (hangover)
Chronic withdrawal
Analgesics
Ergotamine
Caffiene
Narcotics
Headache with extracranial infection
Viral
Bacterial
Headache from metabolic disorder
Hypoxia
High-altitude headache
Sleep apnea headache
Hypoglycemia
Headache or facial pain associated with craniofacial disorder
Cranial disorder
Osteomyelitis
Multiple myeloma
Paget’s disease
Cervical spine disorder (cervicogenic headache)
Eye disorder
Acute glaucoma
Refractive errors
Sinonasal disorder
Acute sinus headache
Rhinogenic headache
Odontomandibular disorder
Periodontis
Pulpitis
Glossitis (burning mouth syndrome)
Temporomandibular joint disease
Cranial neuralgia
Compression of cranial nerve or cervical root 1, 2 or 3 Inflammation of
cranial nerves
Acute herpes zoster
Chronic postherpetic neuralgia
Tolosa-Hunt syndrome
Gradenigo’s syndrome
Trigeminal neuralgia (tic douloureux)
Compression of trigeminal ganglion
Vascular Tumor
Aneurysm
Multiple sclerosis
Glossopharyngeal neuralgia
Occipital neuralgia Anesthesia
dolorosa
Postsurgical after trigeminal rhizotomy
Unclassifiable pain -atypical facial pain
Epidemiology-
Eighty to ninety percent of world population have headache in a
lifetime. 78% is lifelong prevalence of tension-type headache. Compared with this
is the less than 1% likelihood of serious intracranial pathology including tumors,
and the 15% lifetime prevalence of acute nasal or sinus headache. A patient
seeking care for recurrent or episodic headache has an extremely high (94%)
likelihood of having migraine(22).Two-thirds of this care is given in the primary
setting(23). Nevertheless, because of cranial autonomic symptoms or seasonal
periodicity associated with some of the primary headaches, the specialist in allergy
or diseases of the ear, nose, and throat may be the first contact a patient makes in
the search for good care and correct referral. In addition, serious pathology of the
skull, sinuses, or upper dental ridge may be first seen with face and head pain,
making the otolaryngologist the most important arbiter of diagnosis and decision
making.
Primary Headaches-
Migraine-
Migraine is a disabling disorder with a 1-year prevalence of 18%
among females and 6% among males in world (24). Fifty-two percent of
migraineurs remain undiagnosed. Fifty percent of migraineurs miss work 2 days
per month and have reduced work efficiency for 6 days per month. Two-thirds of
migraineurs recognize that this disorder has adversely affected their family life
(25).Migraine was considered a vascular disorder until the mid-1980s, when
Moskowitz proposed the Trigeminovascular Theory of migraine. By using animal
models, he demonstrated that electrical stimulation of the trigeminal nucleus
caudalis in the pons causes plasma protein extravasation from Dural blood vessels.
He concluded that the generation of migraine depended on serotonin mediated
increases in neuronal excitation, not primary vascular reactivity. In humans,
trigeminal activation results in the expression of recognized inflammatory and pro-
nociceptive substances, including calcitonin gene related peptide, neurokinin A,
and substance P. Genetic studies suggest autosomal dominant transmission with
more than 70% of patients having a first-degree relative with migraine. Familial
hemiplegic migraine localizes to defects on chromosome 19p13, which encodes
voltage-gated P/Q-type calcium channels, and to the ATP1A2 gene on
chromosome 1, resulting in dysfunction of the Na-K pump. Genetic polymorphism
studies have implicated alterations in the gene for serotonin receptors in migraine
without aura and in dopamine receptors in migraine with aura.
Figure 1- LOCATION OF HEADACHE IN MIGRAINE
[Supraorbital,Facial ,Frontal, Parietal,Occipital ,Temporal pain,photophobia,Pallor
or flushing]
Migraine with and without Aura-
Migraine aura occurs consistently in 15% to 25% of migraineurs.
Aura is a localizable and fully reversible neurologic deficit preceding head pain,
which results from progressive neuronal dysfunction spreading across the cerebral
cortex. Studies including single-photon emission computed tomography (SPECT),
positron-emission tomography (PET), functional MRI, magnetic resonance
spectroscopy (MRS), and magneto encephalography have bolstered this
hypothesis. Serotonergic, noradrenergic, and dopaminergic pathways; hormonal
regulation, especially estrogen; and hypothalamic and deep brainstem structures
are involved in the ultimate expression of migraine. Thus migraine can be
described as neuronal sensitization and neurogenic inflammation in a milieu of
multiple neurobiologic influences. The goal of migraine treatment is to attenuate
neuronal irritability and neurogenic inflammation while targeting central
mechanisms to abort or prevent headaches and associated disability.
Figure 2- Alice inWonderlan syndrome.This shows the sense of being too large for one’s surroundings
Table 5-
DIAGNOSIS ICHD CRITERIA FOR MIGRAINE
1.1 Migraine without aura
A]Headache attacks lasting 4 to 72 h (untreated or successfully treated)
B]Headache has at least two of the following characteristics
Unilateral location
Pulsating quality
Moderate or severe intensity
Aggravation by or causing avoidance of routine physical activity (e.g., walking or
climbing stairs)
C]During headache, at least one of the following:
Nausea or vomiting
Photophobia and phonophobia
D]Not attributed to another disorder
1.2 Migraine with typical aura
A]At least two attacks
B]Aura consisting of at least one of the following but no motor weakness:
Fully reversible visual symptoms including positive features (e.g., flickering
lights, spots, or lines) and/or negative features (i.e., loss of vision)
Fully reversible sensory symptoms including positive features (i.e., pins-and-
needles) and/or negative features (i.e., numbness)
Fully reversible dysphasic speech disturbance
At least two of the following:
Homonymous visual symptoms and/or unilateral sensory symptoms
C]At least one aura symptom develops gradually over 5 min, and/or different aura
symptoms occur in succession over 5 min
D]Headache fulfilling criteria for 1.1 Migraine without aura begins during the aura
or follows within 60 min
E]Not attributed to another disorder
Migraine and Sinus Headache-
Among patients diagnosable with migraine, only 19% identify their
diagnosis correctly. Twenty-eight percent of patients report sinus as their cause for
headache, and 34% called them tension. In one study of migraineurs, 42%
received an incorrect diagnosis of sinus headache (23)and 32% reported being told
they were tension type.
The potential confusion with sinus headache stems from long-held
beliefs about location of pain. Nasal, paranasal, or periorbital pain merges with
temporal throbbing. During migraine attacks, autonomic symptoms occur in 46%
(26), and two-thirds of patients may describe nasal stuffiness or drainage (27). Eighty
percent of patients complaining of recurrent sinus headache have migraine, and the
response to specific migraine therapies, including the triptans, is excellent.
Headache is a minor criterion of the American Association of Otolaryngologist
Head and Neck Surgeons (AAO-HNS) criteria for sinusitis ,making it more
important for the otolaryngologist to recognize the episodic, recurrent, and
treatable migraineur before assessing for definitive or ongoing treatment (27).
Migraine Treatment: Acute and Preventive-
Treatment of migraine begins with clear diagnosis and
knowledge of its pathophysiology. Acute treatment of headache should be
stratified to the level of disability in the patient. Nonspecific therapies include
nonsteroidal antiinflammatory drugs (NSAIDs), sympathomimetic including
caffeine, and analgesics. Frequent use of many of these has been associated with
substance-withdrawal headache and analgesic rebound, now termed medication-
overuse headache. For moderate to severely disabling headache, specific
medication should be used. The most specific of these are triptans. They bind to
serotonin receptors (5HT1D/B) on trigeminal nerve endings to halt neurogenic
inflammation in addition to binding to dural blood vessels to reduce painful
swelling. No class effect of triptans exists, and if one is not effective, then another
may be tried. Side effects include chest symptoms, nausea, and asthenia. They are
contraindicated in patients with uncontrolled hypertension or a history of cerebral
or coronary artery disease but are generally extremely safe and effective. A
growing body of evidence supports early treatment during the mild phase of
migraine headache. Cutaneous allodynia, a lowering of pain thresholds and
increased sensory awareness of the head, neck, and extremities during the full-
blown migraine attack, may be a marker for response to specific migraine
medications. Triptans are more costly than nonspecific therapy, but economic
analyses point to cost savings and decreased disability when triptans are used in
patients with moderate to severe headache (28).
Table -6
Almotriptan 12.5 mg Pills
Eletriptan 20/40 mg Pills
Frovatriptan 2.5 mg Pills
Naratriptan 2.5 mg Pills
Rizatriptan 5/10 mg Pills/melts
Sumatriptan 50/100 mg Pills
5/20 mg Nasal spray
6 mg Injection
Zolmitriptan 2.5/5 mg Pills and melts
5 mg Nasal spray
Dihydroergotamine 1 mg IV/IM
4 mg IN
Start low and increase dose slowly by using long-acting preparations or once-daily
dosing to enhance compliance.
 Use an adequate trial of 2 to 3 months at an appropriate dosage.
 Avoid interfering, overused, and contraindicated medications.
 Evaluate therapy with regular follow-up, including headache calendars.
 Continue for 6 to 24 months.
 Attempt to taper and discontinue when headaches are well controlled.
 Be aware of drug interactions.
 Give special concern for women during childbearing years.
Tension Type Headache
Episodic tension-type headache is the most common head-pain
syndrome. It is characterized by a gradual onset of bilateral, nonthrobbing, aching
pain over the frontal and temporal regions, often spreading to involve the occipital,
posterior cervical, and trapezius musculature. The pain worsens as the day goes
on. Associated symptoms such as nausea and vomiting are rare, and patients
usually can continue activities of daily living during the headache. The headaches
are not seasonal and do not wake the patient from sleep. Adults rarely seek
medical care for occasional tension headaches (29).Chronic tension-type headache
is responsible for 15% of daily headaches. The patients seeking medical care for
chronic, persistent, or recurrent headaches most often are first seen with
transformed migraine. The most commonly encountered problem in this group is
analgesic rebound headache and depression. Combination therapy, including
limited NSAIDs and antidepressants, is the most effective treatment.
The causes of tension-type headache are poorly understood
despite its well-described symptom profile. No firm evidence exists for the role of
muscle contraction or spasm in these patients. Recent experimental evidence
implicates dopamine, endocannabinoids, and the endorphins/ enkephalins in
tension-type headache. Muscle relaxants, massage, and biofeedback can be very
effective in some patients with the typical clinical features, whereas other patients
require antiinflammatory medications, antidepressants, or both.
Figure 3-TENSION HEADACHE
Table 7-
Diagnostic Criteria for Episodic Tension-Type Headache
A. At least 10 previous headache episodes fulfilling criteria B through D;
Number of days with such headaches: less than 180 days per year
B. Headache lasting from 30 minutes to 7 days
C. At least two of the following pain characteristics:
1. Pressing or tightening (nonpulsating) quality
2. Mild or moderate intensity
3. Bilateral location
4. No aggravation by walking stairs or similar routine physical activity
D. Both of the following:
1. No nausea or vomiting (anorexia may occur)
2. Photophobia and phonophobia are absent, or one but not the other is present.
Trigeminal Autonomic Cephalalgia Including Cluster Headache-
Uncommon and unfamiliar except for CH, the trigeminal
autonomic cephalalgias (TACs) typically are initially seen with shorter-duration,
focal, and side-locked  head pain associated with ipsilateral autonomic features.
This suggests significant but abnormal activation of the cranial autonomics and
trigeminal-parasympathetic. These may mimic pathology in orbital structures or
the sinuses. For this reason, delay in correct diagnosis of CH may range from 7 to
16 years. Early recognition spares the patient years of untreated and often
extremely severe pain. These groups of headaches appear in episodic and chronic
forms. All forms of the TACs have been associated with trigeminal neuralgia in
case reports and case series (30).
Cluster Headache-
CH is not common disorder. It is abrupt in onset , unilateral,
blinding, and less-duration attacks .Among the primary headaches, CH pain is  the
most severe pain, and the accompanying autonomic features may confuse the
diagnosis with pathology in sinuses orbital or periorbital areas. Awakening the
patient from sleep at a time when dreaming is presumed to occur leads to sleep
evaluations, and CH's seasonal or circannual occurrence implies botanical allergy.
Secondary causes of CH can include cranial, cervical, or vascular disorders. The
carotid artery, cavernous sinus, and various brain structures, including the
periaqueductal gray matter, appear to participate in pain generation and
modulation associated with this disease (31).
CH occurs in 0.2% to 0.6% of the population, with a male-to-
female ratio of 4:1 to 12:1. Recent studies have suggested that although the gender
ratio of CH may be changing, the overall prevalence is stable for the last 3 to 4
decades. Genetic studies suggest autosomal dominant transmission with a low
frequency of the susceptibility allele. During active periods, most commonly in the
spring and autumn, clusters of individual headaches lasting between 30 and 180
minutes occur daily, with episodes lasting weeks or months. The majority of
patients have episodic, recurrent attacks of unilateral, temporal, or periorbital pain
associated with autonomic features including rhinorrhea, ptosis, lacrimation,
miosis, and ipsilateral stuffiness. In a chronic disorder, daily attacks of typical CHs
persist.
Episodic cluster is gaps in time between painful periods.
Chronic cluster is unremitting. Episodes occur once or twice per year in 75% of
patients, with a typical episode lasting approximately 2 months. Attacks typically
last between 72 and 159 minutes, with attack frequency between two per week and
five per day, and 73% of patients have a predictable onset of attacks at night. Of
episodic patients, 43% describe a seasonal onset, and chronic sufferers also
describe seasonal exacerbations.
Figure 4-CLUSTER HEADACHE
A patient of Bayard T. Horton. Horton is called as ‘father of cluster headache’. He
described features of cluster headache and he used oxygen for treatment. The
patient has some of the typical ‘leonine facies’ features recognized in cluster
headache: deep nasolabial folds, peau d’orange skin and squared jaw.
Table 8-
DIAGNOSTIC ICHD CRITERIA FOR CLUSTER HEADACHE
Cluster headache
A]At least five attacks fulfilling criteria
B]Severe or very severe unilateral orbital, supraorbital, and/or temporal pain
lasting 15 to 180 min if untreated
C]Headache accompanied by at least one of the following:
Ipsilateral conjunctival injection and/or lacrimation
Ipsilateral nasal congestion and/or rhinorrhea
Ipsilateral eyelid edema
Ipsilateral forehead and facial sweating
Ipsilateral miosis and/or ptosis
A sense of restlessness or agitation
D]Attacks have a frequency of from one every other day to eight per day
E]Not attributed to another disorder
Episodic cluster headache
A]Attacks fulfilling criteria A to E for 3.1 Cluster headache
B]At least two cluster periods lasting 7 to 365 days and separated by pain-free
remission periods of 1 month
Chronic cluster headache
A]Attacks fulfilling criteria A to E for 3.1 Cluster headache
B]Attacks recur over >1 year without remission periods or with remission periods
lasting <1 month
Paroxysmal Hemicrania-
These consists of daily attacks of severe unilateral orbital,
supraorbital, or temporal pain. The attacks are shorter, lasting 2 to 30 minutes, and
they occur 5 or more times per day. They are accompanied by ipsilateral eye
tearing and redness, eyelid edema, ptosis, nasal congestion or rhinorrhea, or a
combination of these. A major difference from CH is the female predominance
and the diagnostic response to therapeutic doses of indomethacin, up to 150
mg/day. The chronic form, which lasts more than 1 year without remission, was
first to be recognized, although episodic cases do occur.Paroxysmal hemicrania is
rare and appears in the middle years (mean, 33 years; range, 3 to 81 years). In
patients presenting with this unusual short duration headache, MRI is indicated. In
the presence of a normal study, a diagnostic trial of indomethacin should be given.
Short lasting Unilateral Neuralgiform Headache Attacks with Conjunctival
Injection and Tearing (SUNCT)-
This rare syndrome is a diagnosis of exclusion. SUNCT is seen
initially at a mean age of 50 years (range, 23 to 77 years). Attacks of strictly
unilateral orbital, supraorbital, or temporal pain lasting 5 to 240 seconds occur
with a frequency from 3 to 200 per day. They are accompanied by prominent
lacrimation and redness of the ipsilateral eye. Workup includes MRI scan with MR
angiography (MRA). No adequate therapy has been found for the treatment of
SUNCT. Trials have included carbamazepine, valproate, lamotrigine, azathioprine,
prednisone, nifedipine, and oral sumatriptan. It can be worsened by verapamil and
omeprazole. Mimics include vascular and compressive lesions affecting the
trigeminal nerve and posterior fossa or craniocervical lesions or malformations.
Other Primary Headaches
This collection of odd headaches includes many paroxysmal head pains that occur
spontaneously and often in odd circumstances.
Primary stabbing headache or ice-pick pains are transient and
localized stabs of pain in singles or series, predominantly in the distribution of the
first trigeminal division, lasting up to a few seconds in the absence of another
disorder. They are more common in patients with migraine or CH.
Cough headache is sudden and may be instantaneous or last up
to 30 minutes. It is brought on by coughing, straining, or Valsalva maneuver and
requires MRI scanning because it may be present with Arnold Chiari type I
malformations, carotid or vertebrobasilar disease, or aneurysms.
Primary exertional headache is a pulsating headache lasting
from minutes up to 2 days and is predictably precipitated by exercise. Heavy
exertion, such as that done by weight-lifters also is recognized as a cause. Workup
is the same as for cough headache. Indomethacin may be used in both of these.
Headache associated with sexual activity occurs during
preorgasm and usually is a dull ache involving the head, neck, and jaws, whereas
orgasmic headache is explosive, occurs at orgasms, and with its first occurrence
mandates CT scan to rule out subarachnoid hemorrhage. Prevention of headache
may be attempted by using indomethacin, triptans, or standard antimigraine drugs.
Hypnic headache is a rare headache that occurs only during sleep,
lasts 15 minutes or more, and first occurs after age 50 years. Unlike CH, no
autonomic features are present. Caffeine and lithium are effective treatments.
Thunderclap headache resembles subarachnoid hemorrhage, with
sudden onset of maximal pain. CT is mandatory to rule out hemorrhage.
Hemicrania continua is a chronic and continuous unilateral headache
of moderate intensity lasting more than 3 months with conjunctival injection, nasal
congestion or rhinorrhea, or ptosis/miosis associated with episodic severe pain. It
is distinguished by its unique response to indomethacin.
New-daily persistent headache is a difficult and controversial entity
in which chronic continuous bilateral headache with a pressing or tightening
characteristic and no other classic migraine features starts one day and does not
end. The importance of ruling out secondary headaches, including high or low
CSF pressure, posttraumatic, infection, or new-onset chronic migraine, is
paramount. Adequate treatment is difficult and usually requires specialty referral.
Secondary Headaches-
The International Classification of Headache Disorders recognizes
myriad secondary headaches. The majority of these do not have distinctive
features of pain in terms of location, duration, or quality, and yet for some,
associations make diagnosis and evaluation relatively straightforward. It is
recognized that a preexisting primary headache may worsen in frequency or
severity in relation to a secondary headache, making diagnosis and treatment more
difficult. In cases involving legal complications, this may present additional
challenges to the treating clinician. A selected group of these is presented for
review, as they may be seen by otolaryngologists.
Headache Attributed to Head and Neck Trauma-
Headache after head trauma becomes a problem most often when
it occurs in association with the other manifestations of posttraumatic syndrome:
depression, somatic preoccupation, and sleep disturbance. The headache can have
phenomenology similar to that of any of the primary headaches. Most patients
describe pain resembling tension-type headache. The key to treating this group of
disorders, especially in the chronic form, is to assess the patient as if he or she
were describing a primary headache and then to treat what you see and hear. The
presence of site of injury pain may be particularly difficult, and the treating
physician should be vigilant for signs and symptoms of CSF leak, intracranial
hypertension, or hydrocephalus.
Treatment consists of reassurance and medications used in
primary headache disorders. Unfortunately, acquired headache may not respond
with the same predictability as primary headache with the same phenomena.
Recognized risk factors for poor outcome include female gender, increased age,
and head position at the time of impact or whiplash.
A fascinating negative correlation exists between severity of
head trauma and complications of headache. Chronic posttraumatic headache
merges with the posttraumatic syndrome, which includes disturbances of
equilibrium, decreased concentration and work ability, depression, sleep
disturbances, and irritability. The role of litigation and ongoing legal
complications remains controversial. The treating clinician should establish a
positive relationship with the patient and assess early in the course the likelihood
of recovery. Additional workup and psychological or rehabilitative consultation
should be recommended when appropriate.In adolescents and young adults,
syncope may accompany the other changes. Episodes of altered consciousness
must be differentiated from posttraumatic epilepsy.
Headache and Hematomas-
Headache with epidural hematoma appears rapidly and resolves
within 3 months of evacuation. Headache associated with subdural hematoma
develops within 24 to 72 hours and may become chronic, even after evacuation. In
patients with acute and subacute hematomas, headache occurs in 11% to 53%.
After a chronic subdural hematoma, headache may occur in up to 80%. For an
elderly patient with new-onset headache, for which the trauma history may not be
elicited, the only other clue may be progressive cognitive impairment or subtle
neurologic signs. Treatment is symptomatic. Caution should be exercised when
using sedating or CNS-active medications in elderly or more-infirm patients with
cognitive sequelae.
Postoperative Headache-
Postoperative head and face pain presents great challenges to the
surgeon or consultant. Premorbid primary headache, psychological and surgical
complications, or accompaniments of the primary illness or procedure complicate
diagnosis, testing, and treatment. Large series of outcome data for routine sinus
procedures are not readily available, but serious complications of major surgeries,
including combined procedures with neurosurgery, are addressed.
Postcraniotomy Headache-
In approximately 80% of patients undergoing craniotomy for
causes other than trauma, head pain develops, with resolution in most. In one-
fourth of those surgical patients, more chronic pain may develop. Posterior fossa
procedures, especially suboccipital craniotomies and retromastoid surgeries
performed for acoustic neuromas, may result in chronic headache. Headache is not
a common presenting complaint or symptom of acoustic neuroma. Patients report
headache as a chronic complication in 10% of patients who have surgery for an
acoustic neuroma (32). Additional complaints include hearing loss, facial
weakness, difficulty with balance, orbital pain, and changes in vision. In patients
with small tumors, headaches and balance problems predominate. The etiology of
the postcraniotomy headache appears to be related to chronic meningeal
inflammation, nerve entrapment, neuroma formation, and adhesions. Osteoplastic
cranioplasty may reduce the incidence of long-term complications by preventing
adhesion of muscle and fascia to the underlying dura.
Headache Attributed to Cranial or Cervical Vascular Disorder-
Headache is not a reliable indicator of ischemic
cerebrovascular disease or its results. Approximately one-fourth of patients with
cerebral infraction have head pain as a prominent acute symptom, with a greater
frequency of occurrence in posterior fossa events. It is a rare consequence of
lacunar infarction or transient ischemic attacks. Headache is more common with
intraparenchymal hemorrhages. In those cases, emesis and focal signs of
neurologic dysfunction are almost always more prominent.
Acute Subarachnoid Hemorrhageand Thunderclap Headache-
The sudden onset of severe generalized headache, either the first or
the worst, should alert the practitioner immediately to the possibility of acute
subarachnoid hemorrhage (ASAH) and its dismal outcome, in which 50% may die
and an additional 50% of the survivors sustain significant long-term disability.
Patients may first be seen with focal and unilateral head pain accompanied by
nuchal rigidity, nausea, reduction in levels of consciousness, fever, and rarely
cardiac dysrhythmia. Grade 1 ASAH may appear with only mild to moderate
headache. Localization of the pain to the face is uncommon, although retroorbital
and supraorbital pain is often reported. If acute noncontrasted CT or fluid-
attenuated inversion recovery (FLAIR) MRI fails to demonstrate a cause for
hemorrhage, then a lumbar puncture is indicated. CSF remains xanthochromic for
2 weeks and is found in 70% of patients with ASAH 3 weeks after hemorrhage has
occurred. A third-nerve palsy associated with new-onset or thunderclap headache
may be the only sign of impending aneurysmal rupture.
Other vascular malformations, including ateriovenous
malformations (AVMs), are less specific and may appear with features of primary
headaches, including the trigeminal autonomic cephalalgias. Migraine with aura
has been reported in more than half of women with AVMs. A more usual
presentation is a seizure or strokelike symptoms.
In arterial dissections, headache is a prominent symptom and may
have features of migraine, cluster, or thunderclap headache. In a patient with
retinal signs, acute painful Horner syndrome, or tinnitus, carotid dissection should
be suspected, and duplex carotid sonography, MRA, and angiography should be
performed urgently. Nonsurgical treatment includes acute heparin followed by 3 to
6 months of warfarin with repeated studies, based on original presentation and
recovery.
Cerebral venous occlusions and sinus thrombosis appear with
headache as their most prominent feature and should be suspected in patients with
prothrombotic conditions including pregnancy and the postpartum, malignancy,
and primary or acquired blood diseases.
A last unique headache occurs in pituitary apoplexy, in which
patients may initially have severe acute, retroorbital, frontal, or diffuse headache
accompanied by nausea and vomiting, fever, diminished level of conscious,
hypopituitarism, hypotension, and ophthalmoplegia or impaired visual acuity. MRI
is more sensitive for detecting pathology in the area of the sella turcica, and the
headache and other signs usually resolve within 1 month. Treatment of the
headache should be symptomatic.
Giant Cell (Temporal) Arteritis-
Ninety-five percent of patients with temporal arteritis (giant cell
arteritis) are older than 60 years. They appear with complaints of daily moderate to
severe headache, scalp sensitivity, generalized fatigue, and feelings of being
unwell in nonspecific ways. Unilateral head pain is the rule, but the pain can be
bilateral or in the occipital region exclusively, reflecting the highly regional
distribution of the disease. Brief episodes of sharp, shooting head pain are
sometimes superimposed on a baseline of continuous dull, aching pain. Carotid
artery pain and jaw claudication have been reported. Enlarged, thickened, or
tender scalp arteries are found on palpation of the scalp in about half the cases.
This condition shares the same pathology as polymyalgia rheumatica, and many
patients have overlapping symptoms of extremity pain. The sedimentation rate is
elevated in all but the rarest of cases. Although scalp artery biopsies in the region
of the pain can confirm the diagnosis, skip lesions do occur, leading to false-
negative results. Patients respond with a dramatic reduction in head pain within
days of starting high-dose (60 mg) daily prednisone. Lack of a definite clinical
response to prednisone within several weeks makes the diagnosis much less secure
without a positive biopsy. Prednisone should be tapered after the initial response
and the sedimentation rate returns to normal. The disease may last 1 to 2 years,
during which maintenance steroids are continued. Visual loss is the major
complication and may occur in 30% of untreated cases. Other primary or
secondary intracerebral angiitides appear with fewer classic or diagnostic features
and are usually accompanied by signs attributable to stroke or more diffuse
encephalopathy, although headache occurs in 50% to 80%. In patients with a
history of immune or infectious disorders including human immunodeficiency
virus (HIV), MRI and MRA may be diagnostic, and spinal fluid may show an
increase in white cells and protein.
Headache Attributed to Nonvascular Intracranial Disorders-
Intracranial Hypertension (Pseudo tumor Cerebri)
This syndrome is defined as a daily, diffuse, or constant
nonpulsating pain aggravated by coughing or straining in an alert patient with
papilledema, an otherwise normal neurologic examination (with the exception of
an enlarged blind spot, subtle visual field defect, or sixth nerve palsy), a normal
CT scan showing no intracranial mass or hydrocephalus, CSF pressure greater
than 200 mm H2O in the nonobese (>250 mm H2O in the obese), and normal CSF
chemistries and cultures. MRI may show Chiari malformation. Intracranial
hypertension shares many of the symptoms that accompany a brain tumor,
including intermittent headache with variable or increasing intensity. Associations
may include predisposing mastoid or inner-ear infection; menstrual irregularity or
other endocrine abnormality; recent weight gain; or exposure to steroids, vitamin
A, tetracycline, or nalidixic acid. Tinnitus or transient visual obscurations or
dimming may be the first clinical symptom.
In a study of 85 patients with transformed migraine or chronic
daily headache, 12 patients were found to have increased intracranial pressure,
transient visual obscurations, or visual field defects. Their acute headaches
responded to ergots, dihydroergotamine or sumatriptan, and preventive
medications including acetazolamide or furosemide were effective. I recommend
spinal tap for all patients with chronic headache. Treatment includes weight
reduction, low-salt diet, and medications directed at reducing CSF production
(acetazolamide and furosemide, used separately or together). In chronic cases with
visual field loss not responding to diet and medications, CSF diversionary
procedures (including lumbo peritoneal or ventricular shunting or optic nerve
sheath fenestration) may be necessary. Sleep apnea should be considered, and
detailed sleep history and overnight sleep study are strongly recommended.
Headache Attributed to Low Cerebrospinal Fluid Pressure-
Low-pressure headache (LPH) is a symptomatic, secondary headache that can
appear hours and days after a surgical procedure, trauma, or spinal tap. In rarer
cases, it can occur spontaneously with a long clinical course. Clinical findings can
include changes in mental status, cranial nerve dysfunction, and systemic signs
including those complaints typically associated with migraine. Diagnostic findings
on MRI consist of diffuse meningeal enhancement with or without Chiari
malformation (33).
Spinal tap may reveal low, absent, or negative pressure, with
normal fluid more the rule than not. Improvement with epidural blood patch
should be expected even if cause is unknown, although repeated treatments may be
necessary and incomplete recovery does occur. Spontaneous LPH may occur in
connective tissue disorders, and further evaluation should be considered in those
with historic or clinical signs of hyperextensible joints, Marfan syndrome, or
disorders of the large vessels including carotid or abdominal dissection.
Symptomatic treatment with nonspecific analgesics also is indicated. Spinal-tap
headache may occur in more than 20%, with the highest incidence in thin female
patients. No specific positioning of the patient after lumbar puncture (e.g., supine,
prone, or lateral decubitus) has been shown to reduce the occurrence of LPH.
Treatment of headache is symptomatic by using oral or intravenous caffeine or
standard analgesics. Blood patch performed by a trained anesthesiologist can be
curative. In chronic, severe LPH, radionuclide CSF flow studies and MRI or
standard myelography should be repeated. LPH represents the outcome of
hydrodynamic changes and mechanical forces influencing craniocervical
nociception and thus is a true secondary headache, no matter what its features.
Headache that worsens with standing and improves with recumbency remains an
important consideration in the evaluation of a patient with recent-onset or, in rarer
cases, chronic headache.
Infection of the Nervous System
Infection producing headache is usually not a diagnostic
problem with associated systemic illness, stiff neck, and fever. However,
nonspecific headache without the other findings can be part of the picture in
epidural abscess; fungal, tuberculous, or luetic meningitis; central nervous system
acquired immunodeficiency syndrome (AIDS); and meningeal sarcoidosis.
Diagnostic lumbar puncture with culture and antigen studies should be performed
after CT or MRI studies of the head have ruled out an intracranial mass.
Recommended studies include CSF VDRL, cryptococcal antigen, and angiotensin-
converting enzyme levels in addition to bacterial, viral, and tuberculosis cultures.
AIDS patients may have chronic headache in the absence of meningitis or cerebral
abscess. The headache is nonspecific and is most often a tension-type headache.
Any patient with immunocompromise and new-onset or subacute progressive
headache should be evaluated for infection. The patient with preexisting primary
headache and change in pattern, with systemic signs of infection, should be
evaluated as if no prior history existed. Nonspecific findings on CSF, including
low-grade lymphocytic pleiocytosis or increases in protein, may occur without
establishing a firm diagnosis. A rare but benign syndrome of migrainous headache
and CSF pleiocytosis has been recognized.
Headache or Facial Pain Attributed to Disorder of Cranium, Neck, Eyes,
Ears, Nose, Sinuses, Teeth, Mouth, or Other Facial or Cranial Structures-
This large category of head, neck, and face pains remains
controversial, and many specialists in different areas disagree on the history of
these disorders. It must be remembered that the majority of patients with these
complaints will have primary headache, especially migraine. A detailed history
helps to rule out serious pathology of these vital structures. Monocular eye
complaints should be urgently evaluated. Acute glaucoma occurs with orbital or
retroorbital pain, increased intraocular pressure and conjunctival injection,
clouding of the cornea, or visual disturbance and resolves with treatment.
Refractive errors rarely cause adult headache. Ocular inflammatory disease such as
iritis, cyclitis, infection, trauma, or granulomatous infiltration may be
distinguished by anatomic site, temporal course, or type of inflammation.
Resolution follows proper treatment of the underlying cause.
Headaches attributed to disorders of the ear are always
accompanied by otalgia. Lesions of the outer ear, tympanic membrane, and middle
ear may give rise to primary otalgia and headache. Referred otalgia may result
from fifth, seventh, ninth, and tenth cranial nerves, all of which project to the
auricle, external auditory canal, tympanic membrane, and middle ear. Evaluation
should include physical examination and imaging with MRI.
Sinus Headache-
Sinus headache is accompanied by pain in the face, ears, or teeth
accompanied by clinical, endoscopic, and radiologic or laboratory evidence of
acute or acute-on-chronic rhinosinusitis that develops simultaneously and resolves
within 7 days after infection remits or is successfully treated. Clinical symptoms
include purulence in the nasal cavity, nasal obstruction, hyposmia, anosmia, and
fever. Chronic sinusitis is not validated as a cause of headache or facial pain unless
relapsing into an acute stage (34). Deviation of the nasal septum, hypertrophy of
turbinates, atrophy of sinus membranes, or mucosal contact points have not been
validated as causes of headache. Disease in the sinuses may appear with frontal
pain or pain radiating behind the eyes or to the vertex (frontal), over the antral or
temporal area (maxillary), between and behind the eyes or to the temporal area
(ethmoid), or between or behind the eyes or the vertex (sphenoid). In the absence
of rhinosinusitis, the recurrent, if even occasional headache sufferer, should be
considered for migraine diagnosis, referral, and treatment.
Sinusitis-
Sinusitis is a clinical diagnosis based largely on history and
physical examination findings. In 1997, the Rhinosinusitis Task Force of the
American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNS)
attempted to create a uniform diagnostic paradigm for sinusitis by organizing
common sinonasal symptoms and signs into major and minor factors. The
presence of two or more major factors or one major and two minor factors is
considered suggestive of sinusitis.
Table 9-
Major and Minor Factors Associated with the Diagnosis of Rhino sinusitis
Major factors
• Facial pain/ pressure
• Facial congestion/ fullness
• Nasal obstruction/ blockage
• Nasal discharge/ purulence/ discolored postnasal discharge
• Hyposmia/ anosmia
• Purulence in nasal cavity on examination
• Fever (acute rhinosinusitis only).
Minor Factors
• Headache
• Fever (in non-acute cases)
• Halitosis
• Fatigue
• Dental pain
• Cough
• Ear pain/ pressure/ fullness.
Acute rhinosinusitis is defined, in part, as having a duration of less than or
equal to 4-weeks.The next category is “sub-acute”, which is defined by a
duration of 4-12 weeks.
“Recurrent acute” is defined as four or more episodes of rhinosinusitis per year
with complete resolution between episodes.
Ultimately, however, the common pathway of acute sinusitis is
thought to be presence of bacteria in a sinus cavity with an obstructed ostium.
In addition, abnormalities of the quantity or consistency of the sinonasal
secretions can affect mucociliary clearance and promote bacterial growth.There are
multiple factors that can lead to anatomic obstruction of sinus ostia. In most
cases, it is edema secondary to inflammation that constricts the small sinus
openings in a reversible fashion.
Examples of anatomic obstruction would include septal deviations,
polyps, nasal tumors, foreign bodies or post-surgical synechiae. Once the
ostium becomes occluded, a local hypoxia develops in the sinus cavity and
sinus secretions accumulate. This combination of low oxygen tension and a rich
culture medium of secretions allows exponential bacterial growth to occur within
the sinus.
Chronic Rhinosinusitis
Rhinosinusitis lasting longer than 12 weeks is classified as
chronic. If the symptoms worsen periodically, the AAO-HNS task force
separately categorizes, this as acute exacerbations of chronic rhionosinusitis.
Multiple episodes of acute sinusitis themselves may cause scarring and mucosal
dysfunction that lead to chronic sinus infections.
Diagnosis of Rhinosinusitis
History: The diagnosis of rhinosinusitis is made difficult by the similarity in
symptomatology with allergic rhinitis and acute viral rhinitis. In rhinosinusitis,
the most common complaints are nasal obstruction and nasal congestion. A
history of “cold” that lasts longer than 10 days especially with green nasal
discharge, is suspicious for sinusitis. In acute sinusitis, pain over the maxillary
or frontal regions can be a prominent feature in the patients history.
Ethmoid sinusitis classically causes pain between or behind the eyes.
Physical Examination
The external findings in sinusitis may be limited and non-specific. Anterior
rhinoscopy can reveal mucosal hyperemia and edema of the septum and
inferior turbinate. In recent years, there has been tremendous advance in the use
of nasal endoscopies for the diagnosis of nasal and sinus disease.
Radiology
Since rhinosinusitis is primarily a clinical diagnosis and considering the
improvements in diagnostics brought about by endoscopy, there is a limited role
for radiologic studies in the initial assessment of suspected sinusitis.
Certainly there are situations in which imaging studies are needed for
evaluation of the sinusitis, for example, clinical sinusitis that fails to resolve
with medical therapy or persistent sinus symptoms without endoscopic
evidence of disease.
Figure 5 - X-Ray PNS – Female showing spur impinging on to the inferior
turbinate which was cause of headache
Figure-6: X-Ray PNS of Child showing anterior deviation of Septum
Figure 7- X-Ray PNS of middle aged male showing DNS and spur with
bilateral maxillary sinusitis
Figure 8 - 58 year old female patient with fever, running nose and sudden
onset of headache showing bilateral sphenoid and ethmoid sinusitis.
Figure 9 - 61 year old male patient with diffuse headache and fever for one
month showing bilateral ethmoid and frontal sinusitis.
Figure 10 - 23 year old male patient with chronic headache showing bilateral
sphenoid sinusitis.
Figure 11-17 year old male patient with chronic diffuse headache showing
deviated nasal septum to the left.
Figure-12: Instruments used for functional endoscopic sinus surgery
Figure-1 Figure 13- Endoscopic photograph showing suction in the maxillary sinus ostium
Medical Therapy-
Acute Rhinosinusitis-
Once the diagnosis of acute sinusitis is ensured, the goal of
therapy is to prevent disease progression and the possibility of serious
sequelae35.In three of four randomized trials reviewed by Hueston et al, the use
of antibiotics was supported by a more rapid resolution of symptoms36.In 1995,
sinusitis was the fifth leading diagnosis for which antibiotics were prescribed
nationwide37.
The selection of first-line antibiotics for acute sinusitis is
directed by the knowledge of the most common pathogens. Typically, patients
will be seen initially by their primary care physician and treated with
inexpensive agents like amoxicillin or trimethoprim sulfamethoxazole. The
choice of a second line antibiotic is dependent on a number of variables
including patient allergies, dosing schedule, proven efficacy, physician
experience and the patients previous response history as well as resistance
patterns.β-lactam cephalosporin have been the most common secondline agent.
Finally, the newer fluoroquinolones such as levofloxacin, moxifloxacin and
gatifloxacin are good second-line agents for patients with activity against
S.pneumoniae. Symptoms should begin to improve within 48-72 hours and it is
important to maintain appropriate follow up to ensure that the complete course of
antibiotics is taken.
Chronic Rhinosinusitis-
In chronic sinusitis, the microorganisms primarily involved
are coagulase positive and coagulase negative species of staphylococcus and
streptococcus. Antibiotic therapy should therefore be directed at these pathogens,
although resistance is a constant problem38.
Surgical Therapy-
Endoscopic Sinus Surgery-
Naumann recognized the relationship between the middle meatal
anterior ethmoid complex, termed the osteomeatal unit, and the pathogenesis of
maxillary and frontal sinus disease39.
After decades of painstaking work, Messerklinger demonstrated
that relieving the osteomeatal unit of obstruction and inflammation could
reverse mucosal disease within the frontal and maxillary sinuses, thus
rejecting the ‘irreversibility’ theory40.
Even though visualization and instrumentation have improved,
endoscopic sinus surgery carries the same risks as traditional sinus surgery.
The majority of dissection is carried out using the 0 degree
endoscope because the angulation of the other telescopes can be disorienting.
The 30 degree endoscope is usually required for examination and manipulation of
the maxillary sinus ostium and frontal recess. The 70 degree endoscope is
excellent for viewing the antrum and for identification of an anterior frontal
sinus. An important principle in endoscopic sinus surgery is the preservation of
the mucosa wherever technically feasible.
Table 10-
Possible Indications for Functional Endosopic Sinus Surgery35
• Recurrent acute sinusitis
• Chronic sinusitis
• Nasal polyposis
• Fungal sinusitis
• Barosinusitis
Advanced techniques
• Tumor removal
• Antral choanal polyp removal
• Dacryocysto rhinostomy
• Encephalocele repair
• Cerebrospinal fluid leak repair
• Pituitary surgery
• Mucocele removal
• Orbital abscess/ cellulitis management
• Orbital decompression
• Septal reconstruction
• Choanal atresia repair
• Epistaxis control
Technique of Diagnostic Endoscopy-
The endoscopic examination of the nasal cavity and of the lateral wall of the nose
is usually accomplished in three steps:
1. Inspection of the nasal vestibule, the nasopharynx and inferior nasal meatus.
2. Examination of the sphenoethmoidal recess and the superior nasal meatus.
3. Examination of the middle meatus.
Figure-14: Position of instrument in case of 0º endoscope
The best endoscopes for the routine diagnostic nasal endoscopic examination are
either the O-degree wide angle 4mm diameter endoscope or the 30-degree, 4mm
diameter endoscope.
Common abnormalities found on diagnostic nasal endoscopy:
Nasal septal deviations
Septal tubercle
Anatomic variation of middle turbinate-
Concha bullosa
Enlarged and anterior extending middle turbinate
Paradoxically bent middle turbinate
• Abnormalities of uncinate process
- Medially bent uncinate process
- Laterally bent uncinate process
- Elongated and enlarged uncinate process
- Pneumatization of uncinate process
• Accessory maxillary sinus ostia
• Ethmoidal bulla70.
Figure 15-View through a 0º endoscope into a right middle meatus: cm-
middle turbinate; pu-uncinate process; be-ethmoidal bulla; an-agger nasi;
s-septum
Figure 16- View into a normal
right middle meatus (arrow
indicates the path into frontal
recess)
Figure 17- Septal spur impinging
into the inferior turbinate
Temporomandibular Disorders
The temporomandibular disorders (TMDs) can occur as diffuse
temporal headache, earache, and facial pain. True TMJ pain is characterized by
tenderness to palpation over the condyle and by pain on jaw movement. Internal
derangements are characterized by anterior and medial displacement of the
articular disk when the teeth are interdigitated in occlusion. About 25 mm of space
between the anterior teeth is the limit of rotational opening because further
opening requires translation of the condyle. Degenerative joint disease (DJD) is
characterized by crepitus and pain on jaw movement. It is usually self-limited and
can be managed with NSAIDs. Most patients have combined muscle and joint pain
with tenderness of the masticatory muscles and worsening with joint movement. A
click on movement may be present. Mouth opening is limited. Management is
similar to that for tension headache. NSAIDs and physical therapy form the
mainstay of treatment. Other methods for muscle pain management such as
biofeedback, trigger-point injection, and physical therapy are useful. Dental splints
may be useful, and referral to dentistry is indicated.
Cranial Neuralgias and Facial Pain
Trigeminal Neuralgia
Trigeminal neuralgia (TN) is a syndrome of repetitive, brief
attacks of severe, sharp, jabbing, or lancinating pain occurring in the distribution
of one or more divisions of the fifth cranial nerve. Although individual attacks of
pain are very brief, lasting seconds at most, they may occur many times in rapid
succession and many times a day, resulting in significant functional impairment.
Spontaneous remissions lasting many months or even years are not uncommon.
The typical syndrome occurs in patients older than 50 years and runs a progressive
or fluctuating course over many years. The pain is localized most often in the
second or third divisions of the nerve, with triggers commonly found at the corner
of the mouth or lateral aspect of the nose. Triggers are small areas on the face that
precipitate an attack when touched. Triggers also may arise in deeper structures
such as the sinuses, oral mucosa, periodontal ligaments, fascia, and muscles. The
syndrome is not associated with facial numbness, weakness, loss of corneal reflex,
change in taste or smell, or other cranial nerve impairment. The presence of those
findings should suggest another diagnosis, such as brain or meningeal tumor,
nasopharyngeal pathology, chronic basal meningitis, Raeder syndrome, or internal
carotid aneurysm. Diagnostic workup of patients with TN must include MRI of the
head with and without contrast. A lumbar puncture should be performed in
patients in whom the MRI does not clearly demonstrate a cause. CSF should be
sent for Lyme titers, cryptococcal antigen, VDRL, and cytology, in addition to the
routine cells, protein, glucose, TB, and bacterial cultures. CSF electrophoresis and
immunoglobulin G (IgG)-to-albumin ratio with a paired blood sample should be
evaluated for multiple sclerosis (MS). Medical treatment includes carbamazepine,
gabapentin, baclofen, phenytoin, sodium valproate, or chlorphenesin .Adjunctive
therapy consists of tricyclic antidepressants and NSAIDs. Opiates are effective in
only a few patients. Surgical treatment is considered when medications cannot
control the pain. Percutaneous rhizotomy is now replacing more complicated open
procedures.
Glossopharyngeal and Other Less-Common Neuralgias
The glossopharyngeal nerve also is subject to development of
neuritic-type pain similar in its temporal profile, pain characteristics, and intensity
to that of TN. Paroxysmal attacks of unilateral, severe transient pain in the ear,
base of the tongue, tonsillar fossa or beneath the angle of the jaw can be
precipitated by swallowing, chewing, talking, laughing, or yawning. These are
stereotyped in the individual patient, and other causes must be ruled out. Workup
and treatment are the same as for trigeminal neuralgia. Nervus intermedius
neuralgia is felt in the posterior wall of the auditory canal. Superior laryngeal
neuralgia is a very rare disorder first seen with pain in the lateral aspect of the
throat, submandibular region, and underneath the ear, precipitated by swallowing,
straining of the voice, or head turning. A trigger point overlies the hypothyroid
membrane. Nasociliary neuralgia is a paroxysmal or constant pain in the region of
the supraorbital notch with tenderness over the nerve; the pain is abolished by
local injection of anesthetic. Occipital neuralgia is found in the distribution of the
greater, lesser, or third occipital nerve and responds to local injection. Neck tongue
syndrome is a symptom of probable compression of the second cervical nerve and
its connections to the lingual and hypoglossal nerves. The sudden onset of pain is
felt in the neck or occiput and ipsilateral tongue and may be precipitated by
sudden turning of the head. In all these rare neuralgias, thoughtful history,
examination, and radiologic or laboratory testing is indicated.
Optic neuritis appears with unilateral or bilateral dull eye pain
worsening with eye movement. It associates with visual impairment due to central
or paracentral scotoma. Pain may precede visual impairment by a month or less,
and vision usually improves within 4 weeks. It is a cardinal presenting symptom in
approximately 20% of patients with MS. Other head or facial pain may be
attributed to MS. This may be unilateral or bilateral with or without dysesthesia
and may be similar to trigeminal neuralgia. The occurrence of either symptom
should provoke MRI, which may demonstrate demyelinating lesions in the pons,
midbrain, or thalamic connections. Facial pain or headache associated with MS
may wax and wane with the disease.
Herpetic and Postherpetic Neuralgia
Herpetic skin eruption is a common disorder caused by the varicella
zoster virus. The virus infects the trigeminal nerve in childhood as chickenpox.
The virus remains dormant in sensory nerve ganglia for decades and can be
reactivated by trauma or stress or during periods of compromised immune
function. Pain affects the first division in 80% of patients. The reactivated virus is
transported distally in the axon and produces small, crusting pustules on the skin.
The acute infection produces a combination of burning, itching, and lancinating
pain. Secondary infections of the skin worsen the pain. Associated symptoms may
include ocular palsies, tinnitus or hearing loss, and facial weakness. Risk for this
disorder is high in patients with lymphomas or immunocompromise. Antiviral
medications such as acyclovir, NSAIDs, or opioids should be administered for
pain during the acute phase. An oral prednisone taper should be considered. Pain
lasting 2 months or more is called postherpetic neuralgia Opioid analgesics and
NSAIDs often are of little use in this stage. Anticonvulsants are the most useful for
pain management and may be combined with tricyclic antidepressants or baclofen
to control the lancinating and shooting pains. Prognosis for a good response to the
medication or spontaneous recovery worsens with advancing age. Topical
lidocaine patches may be helpful. In refractory cases, surgical interventions may
be of limited utility.
Atypical Facial Pain
Atypical facial pain is described as a chronic burning or aching pain
without focal findings or any discernible etiology. It is a diagnosis of exclusion.
The facial pain is present daily and lasts most or all of the day. It is deep, poorly
localized, usually one-sided, and is not associated with sensory loss or other
physical signs. It may spread from the area of onset to include large portions of the
face. It may be initiated by injury or surgical procedure on the face, teeth, or gums.
Atypical face pain affects women more than men. Age at onset is between 30 and
50 years. Significant psychiatric findings include depression, somatization, and
adjustment disorders in 60% to 70%. Psychiatric assessment is recommended.
Atypical facial pain can be managed with antidepressants or anticonvulsants and
mood stabilizers. These patients are at risk for iatrogenic problems due to multiple
invasive evaluations and excessive medication. Pain associated with nerve injury
and sensory loss is called anesthesia dolorosa. This may be unbearable, complex,
and refractory.
REVIEW OF LITERATURE
Studies of epidemiology need to be population-based to avoid the
risk of biases. This is frequently achieved by administering questionnaires in the
community by interview or via the telephone. The important outcomes of
epidemiology studies are incidence and prevalence .In practice, prevalence is
assessed far more often than is incidence. To obtain further information,
prevalence data is usually analysed for gender, age, race and other social and
epidemiological factors .Overall, almost everyone gets headache: the lifetime
prevalence is estimated as 93%, with a point prevalence of 11% in men and 22%
in women. Prevalence studies, with diagnoses confirmed using the IHS criteria,42
indicate that the only headache subtypes with a prevalence > 1% in the general
population are TTH, migraine and CDH. These headaches are considered
separately below.
Tension-type headache-
The pioneering studies of Rasmussen and colleagues showed
that TTH is very common, indeed almost ubiquitous. The 1-year prevalence of
TTH in Denmark was 63% in men and 86% in women, with a male: female ratio
of 4:5.42 Similar results were reported in a population-based study conducted in
the USA, although with a lower 1-year prevalence of 38%.43The prevalence
decreased with increasing age.42In Denmark, socio-demographic variables o f
m a r i t a l s t a t u s , c o h a b i t a t i o n , e d u c a t i o n a l level, occupational
category of employment status were not significantly associated with TTH.
However, TTH was positively associated with neuroticism, fatigue in both
sexes, time-pressure at work in women and exposure to fumes in men.44 In the
USA, TTH prevalence was associated with increasing educational levels and
prevalence was higher in Caucasians than in African Americans.45
Migraine-
There are relatively few population-based data on the incidence of
migraine. Studies show that incidence peaks in childhood and adolescence, then
declines over time.46,47 The overall incidence per year is about 0.2% for boys and
0.6% for girls. The mean age of incidence is lower for boys than for girls (13.7
versus 17.6 years).48 In contrast, there are large amounts of information on
migraine prevalence. 1-year prevalence rates from population-based studies
conducted around the world are summarised in Table 11.
Table 11- 1 year prevalence of migraine from population-based studies.
Prevalence (%)
Country, year n Age range (y) Men Women Total
USA, 1992 20,648 12–85 5.7 17.6 10.5
Canada, 1994 2,992 18+ 7.4 21.9 15.3
Denmark, 1991 1,000 25–64 5.9 15.3 10.4
Netherlands, 1995 1,008 12+ 5.0 12.0 9.0
UK, 2003 4,007 16–65 7.6 18.3 ND
France, 2002 1,486 15+ 4.0 11.2 7.9
Japan, 1997 1,597 15+ 3.6 12.9 8.4
Malaysia, 1996 595 6+ 6.7 11.3 9.0
Latin America, 2005 2,637 15+ 2.9–7.8 6.1–17.4 ND
ND = No data
The overall prevalence of migraine worldwide seems to be about 10% overall,
6% in men and 15% in women. One large, international prevalence study showed
that migraine without aura was much more common than migraine with aura;
less than one-third of the migraine sufferers experienced aura symptoms.49 The
prevalence of migraine with aura has been estimated at 3% for men and 5% for
women.50
Figure 18 -Gender and age specific prevalence of migraine
Overall, approximately 2–3 times as many women as men report
migraine, most likely due to the influence of female sex hormones. Migraine is
about twice as likely to occur at the time of the menstrual period as at other times
in the menstrual cycle.51 Up to the age of 12, more boys than girls have
migraine, but the female preponderance starts at age 13, when menarche has
usually occurred.52 Prevalence in women increases up to about 40 years, then
declines. A similar pattern is seen in men, with peak prevalence occurring at about
35 years. Prevalence declines thereafter for both genders, and < 5% of the
population is affected after age 70 years.53 .Some studies show a low prevalence
of migraine in certain Asian and African countries, which have been ascribed to
cultural and environmental differences between races. A study in Americans
showed that migraine prevalence was higher in Caucasians (20.4%) than in
African Americans (16.2%) and Asian Americans (9.2%).55 There therefore do
appear to be real racial differences in migraine epidemiology, although the
condition is common in all races. There is some evidence for variations in
migraine prevalence in terms of social forces. The prevalence seems to increase as
the levels of education and income decrease.
Chronic daily headache-
Very few population-based studies have been conducted on
CDH. The available evidence suggests that CDH is a relatively common
condition, affecting about 4–5% of the general adult population56 . CDH can
occur at all ages, from 5 to > 80 years, and without treatment, the condition can
persist for years or decades57 . Population-based studies have provided 1- year
prevalence rates of 2.2% for chronic TTH54,55 and 2.4% for chronic migraine58.
Hemicrania continua and NDPH were reported rarely.56,57 There are difficulties
in assessing the prevalence of chronic migraine (often known as ‘transformed
migraine’), as studies published to date did not use the criteria recently published
by the IHS.43 Further studies are therefore necessary to investigate the
epidemiology of chronic migraine. As with migraine, CDH was much more
common in women than in men.59 A population- based study showed that CDH
was also associated with being Caucasian, lower education status, and in those
with a history of marriage60.Population- and clinic-based studies identified co-
morbid conditions of obesity, diabetes, arthritis, allergy, asthma, hypothyroidism
and hypertension, and associated with daily caffeine consumption and habitual
snoring61,62.New-onset CDH was associated with the baseline headache frequency
and obesity63. In the clinic, the presentation of CDH is typically of daily TTH-like
headaches, with exacerbations of migraine-like headaches64.
Medication overuse headache (MOH) is present in a substantial
proportion of people with CDH. The overall population prevalence of MOH in a
Spanish study was 1.4%, much higher in women (2.6%) than in men
(0.19%)Prevalence increased with age, and the mean age of sufferers was 56 years.
Most patients with MOH have a longstanding history of primary headaches, with a
decade or more of overuse of symptomatic medications.33 A clinic-based study
indicted that MOH was associated with asthma, hypertension and daily caffeine
consumption.Other chronic headaches are much less prevalent than CDH. The best
known, cluster headache, has an overall prevalence of about 0.4%; 0.3% in men
and 0.1% in women.
Several studies demonstrate that the IHS system does not
adequately classify many headache patients. Messinger et al the new IHS criteria
and questionnaire data from two  surveys, classified a clinic-based sample of 410
subjects with a history of  headache for more than 2 years and were unable to
classify 35.9% of the patients. Among them  9.1% had CTTH, and 86%  patients
had some migrainous features.
Solomon and Lipton65 evaluated 100  CDH patients in a tertiary care
center and of them 61% had continuous headache; 39% had intermittent headache
defined  by painless periods for at least 1 hour in at least 4 days a week. While two-
thirds of these patients met the criteria for CTTH, many had migrainous features.
One-third of these patients could not be classified as CTTH because they had too
many migrainous features. Many of these headaches were classifiable as migraine
were it not for their daily occurrence. A large number of patients could not be
classified in the IHS system . Past history of headache is an important part in the
diagnosis. Solomon and Lipton did not propose specific diagnostic criteria for these
disorders and concluded that the IHS criteria should be modified to include TM
(CDH evolving from migraine), and subtypes with and without medication overuse
should be distinguished, both for TM and CTTH.
Sanin et al attempted to validate the IHS criteria in a headache clinic
population.With a random selection of 400 patients  they classified them using the
IHS criteria and concluded that most patients in their clinic had more than one IHS
diagnosis, that CTTH occurring alone is rare, and  classification of chronic headache
needs revision.
Pfaffenrath and Isler investigated the IHS criteria for CTTH in 211
subjects participating in a clinical trial of antidepressant treatment. Daily headache
was present in 56%. Of the remaining 44%, headaches occurred an average of 18
days per month. More than two-thirds met the two major IHS criteria  for CTTH
(bilateral pain, 79%; pressure or tightening, 72%). Fifty-nine percent met all the IHS
criteria for CTTH. However, many symptoms of migraine like unilateral headache,
20%; throbbing, 28%; anorexia, 39%; osmophobia, 25%; phonophobia, 60%; nausea,
53%; and increased pain with physical  activity, 48% were reported. In total, 50% of
all the patients failed to meet one or more of the criteria of migraine. In many of
these patients the symptoms of migraine occurred with headache of mild
intensity.They concluded  that the IHS criteria need to be revised according to  the
classification of daily headache.
Saper found that 80% of his patients with CDH were typically women,
had the migraine onset between 26 and 41 years of age ,frequently clinically
depressed and had superimposed acute bouts of migraine. Many of these patients
overused abortive headache medications and had significant long term improvement
of their headache following detoxification.
Sandrini et al of Italy,classified 90 consecutive outpatients with CDH
and 75% had CDH evolving from migraine,while 16.7% began de novo and 7.7%
had evolved from episodic tension-type headache (ETTH).
Transformed migraine referred to migraine patients having distinct bouts
which evolved into CDH with the disappearance of typical migraine attacks.
Migraine with interparoxysmal headache was defined as recurrent bouts of migraine
with a constant headache of low severity in between attacks.  Mathew demonstrated
the phenomenon of transformed migraine,he reported a series of patients with
distinct attacks of migraine whose headaches evolved over the years into a daily or
near-daily problem.Patients had  both migraine and tension headache features.90%
of them had migraine without aura.
MATERIALS AND METHODS
The present study “A STUDY OF  EVALUATION AND MANAGEMENT OF
PATIENTS WITH   HEADACHE” was conducted in the Department of
Otorhinolaryngology in Thanjavur Medical College, Thanjavur from AUGUST
2011  to October 2013.
Source of Data
Patients for the study were collected from the Department of Otorhinolaryngology,
Thanjavur Medical College Hospital, Thanjavur.
Sample Size
The study included 100 patients and the cases were diagnosed based upon the
clinical examination and investigation.
Inclusion Criteria
Patients presenting with headache for more than 1 month of all age groups and
sexes.
Exclusion Criteria
1. Medically unstable, lethargic, unarousable, agitated or
uncooperative patients.
2. When the information obtained from the study is unlikely to change the patient's
management such as in the situation of advanced care preferences, chronic disease,
or end-of-life.
These patients were evaluated as follows:
Selected patients were subjected to a complete examination
according to a defined proforma.Detailed history with thorough clinical
examination was done. Patients were asked about history of headache, Mode of
onset, Duration of complaint, Continuous or intermittent, Progressive or not ,Site
of pain and radiation, Type of pain, Associated symptoms, Aggravating and
relieving factors, Duration of each attack, Frequency of attack, Time of onset of
attack, Diurnal variation, Treatment taken for the same, Patients suspected of
migraine features were consulted with neurologist and complete clinical and
radiological  investigations have been done. Patients suspected of Tension type
headache were consulted with Psychiatrist and opinion obtained. Patients
suspected of refractive errors were consulted with Ophthalmologist and opinion
obtained.
Routine blood investigations like Hb, TC, DC, ESR, BT, CT
urine for albumin, sugar and microscopy. According to clinical diagnosis
,radiological investigations i.e., X-ray Para nasal sinuses (waters view), CT Para
nasal sinuses, CT Brain ,Orthopantomogram and EEG was advised .DNE was
advised to patients with nasal symptoms.
Acute infections were first treated with medication for 3
weeks.Patients with positive DNE findings and CT PNS findings were advised
FESS. Patients  with migraine were followed by The Migraine Disability
Assessment Test.
Ethical clearance was obtained from the Ethics Committee of
Thanjavur Medical College, Thanjavur.
OBSERVATIONS
A STUDY OF  EVALUATION AND MANAGEMENT OF PATIENTS WITH   HEADACHE
was conducted in Department of ENT, Thanjavur Medical college,thanjavur. A
total of 100 patients with headache were studied for a period of about 2 years
i.e., form August 2011 to October 2013, of which only 21 patients h a v e
s i n u s  h e a d a c h e .
Table 12- Age distribution of Headache
Age group (years)
5 – 10 11- 20 21 – 30 31 – 40 41 – 50 51 – 60
Tension Headache -- 3 14 10 14 5
Migraine -- 3 9 8 3 --
Cluster Headache -- -- 2 - -- --
Sinus Headache 1 3 6 4 4 3
Refractive Error -- 2 1 - -- --
Others -- - 1 2 1 1
The highest age incidence is present in the age group of 21-30 year (33%),
followed by 31-40 years (24%)
Figure 19- Age distribution of Headache
Tension headache is most common in age group of 21-50 years.Sinus headache is
common in 21-30 years of age.
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Table 13- Sex distribution of Headache
Male Female
Tension Headache 30 16
Migraine 7 16
Cluster Headache 1 1
Sinus Headache 12 9
Refractive Error 2 1
Others 3 2
65.22% of the patients of tension headache are males and 69.57% of migraine
patients are Females.So tension headache is common in males and migraine is
common in females.
Figure 20- Sex distribution of Headache
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Table 14-Sex Distribution (Other causes) (n=5)
Male Female
Hypertension 1 1
Trigeminal neuralgia 1
Temporomandibular
joint arthritis
-- 1
Alcoholism 1 -
60% of the patients of headache due to other causes were males and 40% were
females.
Figure 21- Sex Distribution (Other causes) (n=5)
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Table 15-Etiology of Headache with Respect to Clinical Findings
No. of cases Percentage ofRhinogenic causes
DNS 7 33.33
Chronic sinusitis 3 14.29
Osteomeatal complex
disease
7 33.33
Polyp 2 9.52
Allergic rhinitis 2 9.52
33.33% of patients of headache had DNS and 14.29% of the patients had acute
sinusitis, 33.33% of the patients had osteomeatal complex disease and 9.52%
of patients had polyp, 9.52% of patients had allergic rhinitis .
Figure 22- Etiology of Headache with Respect to Clinical Findings
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Table 16- Localization of Headache
Localization No. of cases
Forehead 22
More Than One Site 59
Parietal 9
Occipital and neck 10
Patients with headache in more than one site were maximum i.e., 59%
followed by headache in Forehead 22% .
Figure 23- Localization of Headache
Out of 100 patients,63 patients were having nasal symptoms.All 63 patients were
undergone DNE.Out of which 32 Patients had positive findings.31 Patients had
normal study.32 Patients had DNS with sinusitis,Osteomeatal complex
disease,polyp,acute sinusitis and allergic rhinitis.
Table17- Patients who underwent DNE (n=32)
No. of cases Percentage
Mucosal contact points
present
9 28.12
Mucosal contact points
absent
23 71.82
28.12% of the patients who underwent DNE for headache had mucosal contact
points as the main pathology.
Figure 24- Patients who underwent DNE (n=32)
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Table 18- Patients who underwent FESS due to mucosal contact point (n=9)
No. of cases Percentage
Total relief
from headache
8 88.88
Significant relief 1 11.12
Out of 9 patients diagnosed as having mucosal contact points, 8 underwent
FESS. All the patients are followed for 1 year.88.88% of the patients who
underwent FESS for headache due to mucosal contact points were relieved
totally from headache and 11.12% had significant relief.
Figure 25- Patients who underwent FESS due to mucosal contact point (n=9)
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Table 19-Patients who underwent FESS due to causes other than Contact
Points (n=21)
No. of cases Percentage
Completely free
of pain
7 33.33
Significant
symptom
improvement
3 14.29
No benefit
from surgery
11 52.38
Out of 23 patients of headache due to causes other than contact point, 2
patients were diagnosed as Allergic Rhinitis.They were treated conservatively.21
underwent FESS. Patients who underwent FESS for causes other than
mucosal contact points showed 47.62% improvement in headache and facial pain.
11 Patients with no relief were clinically examined and consulted with
neurologist and 6 patients were diagnosed as tension type headache and 5 patients
were diagnosed as migraine.
Figure 26-
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Migraine-
Acute attack-Patients were advised to stay in dark and quiet room in lying down
with head end elevation and T.Metoclopramide 5mgs+T.Paracetamol 500 mgs
and T.Sumatriptan 100mgs were given.
Prophylaxis-T.Propranalol 40 mgs BD and T.Amitriptyline 50 mgs HS were
given.Patients are followed up regularly at 15 days interval.
The Migraine Disability Assessment Test
1. Number of days in the last 3 months missed for school or office due to
headaches?
2. Was your productivity decreased due to headaches? if yes, Number of
days in the last 3 months ?
3. Number of days in the last 3 months did you not do household work?
4. Was your productivity in household work reduced by half of more
because of your headaches. If Yes ,Number of days in the last 3 months?
5. On how many days did you miss family, social or leisure activities
because of your headaches in the last 3 months?
1] Did you have a headache,If yes how many days in the last 3
months?
(If a headache lasted more than 1 day, count each day.)
2]How painful were these headaches? a scale of 0 - 10, on
average how painful?
(where 0 = no pain at all, and 10 = pain as bad.)
Table 20-
Out of 23 Patients diagnosed as migraine 18 patients had subjective relief of
headache.5 patients had  Significant symptom improvement.
Table 21-
Cases Percentage
Subjective Complete
relief of pain 18 78.26
Significant symptom
improvement 5 21.74
Figure 27-
Tension Headache-
Out of 46 Patients with Tension Type of headache,12 patients were diagnosed as
Episodic Tension Type of headache and 34 patients were diagnosed as Chronic
Tension Type of headache, They were treated with relaxation techniques,
78.26%
21.74%
Completely free of pain
Significant symptom
improvement
MIDAS
Grade Definition
MIDAS
ScoreI Less or no disability 0-5II Disability- Mild 6-10III Disability- Moderate 11-20IV Disability- Severe 21+
physical exercises and T.Amitriptyline 10 mgs once a day in evening. Patients are
followed up regularly at 15 days interval.
Table 22-
Cases Percentage
Subjective complete
relief of pain 40 86.96
Significant symptom
improvement 6 13.04
Figure 28-
Cluster Headache-
Patients were prescribed T.verapamil 240 mg in evening and the patients
improved significantly.
Trigeminal Neuralgia-
The patient underwent EMG , Nerve conduction studies,MRI with contrast.All
were normal.Patient was started T.Carbamazeine 100 mgs daily.He had
Significant symptom improvement.
86.96%
13.04%
Completely free of pain
Significant symptom
improvement
DISCUSSION
The present study evaluates the clinical study of headache and its
management during the period from August 2011 to October 2013 in the
Department of E.N.T., Thanjavur Medical College, Thanjavur.Of the 100 cases
presented with headache only 21 cases were having headache due to rhinogenic
causes. These constituted 21%, which were followed-up.
Age Distribution-
According to study conducted by Pramod Kumar et al 2000, the
majority of the cases of headache belonged to the age group 10-30 years67.In our
study, the majority of the patients had headache belonged to the age group 21-30
years.Thus, it can be concluded that the majority of cases of headache belong to
age group 21-30 years.
Sex Distribution-
Regarding the affection of sexes due to headache our study shows
that males were more affected at 55%.In a study conducted by Pramod Kumar et al
2000 showed male preponderance at 53%. In a similar study conducted by Wenig
et al and Lebovics et al demonstrated a male predominance of headache in both
adults and adolescents68.Thus it concludes that headache is more common in
males.
Localization of Headache-
In a study conducted by Pramod Kumar et al (2000),
localization of headache to forehead was 43% while headache at more than one
site was 19%, pain at glabella 12% and headache at top of head was 9%67
In our study, out of 100 patients of headache ,22 patients had
headache at forehead i.e., 22%, 59 patients had headache at more than one site
i.e., 59%, 9 patients had headache at parietal i.e., 9% and 10 patients had
headache at occipital and neck i.e., 10%.Thus, it concludes that headache is
localized at more than one site majority of cases.
Diagnostic Nasal Endoscopy-
In a study conducted by Parsons DS, Batra PS to analyze the
outcome of care for 34 patients who presented with headaches as one of their
primary sinonasal complaints and were subsequently found to have contact points
between nasal septum and one or more turbinates on diagnostic nasal
endoscopy.
In our study on 63 patients who underwent diagnostic nasal
endoscopy, 9 patiens had mucosal contact points present (28.12%).
Medical Management-
Migraine-
In our study, For migraine e Prophylaxis-T.Propranalol 80mgs and
T.Amitriptyline 50 mgs were given. 18[78.26%] patients had subjective relief of
headache..5[21.74%] patients had  Significant symptom improvement.
In a study conducted by Jackson JL, Shimeall W, Sessums L, et al
likelihood of obtaining at least a 80% reduction in migraine was greater in patients
taking a tricyclic (mainly amitriptyline) as compared to placebo.
A Cochrane Systematic Review of the use of propranolol for
migraine prophylaxis was published in 2004 by Linde and Rossnage  and it
shows 70% reduction in migraine frequency relative to placebo .
Tension Headache-
In our study,for tension headache and T.Amitriptyline 25 mgs once
a day in evening.40 [86.96%] patients had subjective relief of pain.
Lance and Curran’s trials showed low dose tricyclic antidepressants
(mean amitriptyline dose 50 mg/day) reduced headache by at least 70% compared
with placebo .
Cluster headache-
In our study, both patients improved better after taking verapamil sr
240 mg..Leone M, D’Amico D, Attanasio A, et al.’s Double-blind placebo-
controlled trial that evaluated the efficacy of verapamil 360 mg (three divided
dosages) over a 14-day period, a statistically significant reduction in headache
frequency.
Surgical Interventions-
In our study, patients due to mucosal contact points were
advised to undergo functional endoscopic sinus surgery. Out of 9 patients, All
9 patients underwent surgery. Post-operatively, 8 patients (88.89%) had total
relief from headache, 1 patient (11.11%) had significant relief and it correlates
with studies mentioned below.
In a study conducted by Behin F, Behin B, 86% o f
patients underwent surgical intervention for contact points relieved from the
symptoms.
Postoperatively-
88.89% of patients no longer complained of
headache. 11.11% had significant relief69.
In a study conducted by Parsons DS, Batra PS on 34
patients who underwent surgery for contact points reported a reduction in
intensity in 91% of patients and reduction in frequency of headache in 85% of
patients postoperatively35.
Thus, from our study and the above mentioned studies, it is
clear that majority of the patients who underwent FESS for mucosal contact
points are totally relieved of the symptoms.
The remaining 23 patients who had other pathologies i.e., DNS,
osteomeatal complex disease were also advised FESS to get rid of headache.
Out of which 21 patients underwent surgery.
Post-operatively, 7 patients were completely free of pain –
33.33%; 3 patients had significant symptom improvement – 14.29% and 11
patients had no benefit from surgery – 52.38%.
Thus, it showed 47% improvement and correlates with studies
mentioned below:In a study conducted by Welge-Leussen A et al, 10 years
follow up of the patients who had undergone FESS was done. Out of 20
patients, six patients remained completely free of pain (30%), Four had
significant improvement (20%) and Ten (50%) received no benefit from
surgery (overall 50% improvement)70.
In a study conducted in Department of Otolaryngology, Vajira
Hospital, Bankok, 16 patients were operated on by FESS. Their principal
complaint was facial pain or headache. Ten patients had no headache
postoperatively (62.5%) and six patients (37.5%) had a reduction in severity63.
Thus, from the present study and the above mentioned studies,
an improvement in headache in 50% of patients operated for Non contact point
headache can be expected after the patients undergoes FESS for headache.
SUMMARY
1. A total of 100 patients presenting in ENT Department with headache were
taken for study.
2. Out of 100 patients,46 Patients had tension type headache.23 patients had
migraine, 21 patients had headache due to sinogenic causes.
3. Headache can occur at any age. But the highest incidence was noted in the
age group 21-30 years followed by 31-40 years.
4. Sex incidence is slightly more in males (55%).
5. Patients clinically diagnosed as Migraine and tension headache were consulted
with Neurologist and psychiatrist and opinion obtained. Out of which 46 patients
were diagnosed as Tension Type of headache and medical management was given.
Out of 46 patients, 40  [86.96%] patients  had subjective complete relief of
pain.6 patients had Significant symptom improvement.
6. 23 patients were diagnosed as Migraine and medical management was given. Out
of 23 patients,18  [78.26%]patients  had subjective complete relief of pain. 5
[21.74%] patients had Significant symptom improvement.
7. In the patients of headache due to sinogenic cause 3 patients (14.29%) had
chronic sinusitis, 7 patients (33.33%) had DNS, 7 patients (33.33%) had
osteomeatal complex disease (OMD), 2 patients (9.52%) had polyps, 2 patients
(9.52%) had allergic rhinitis.
8. Headache was localized to forehead in 22 patients (22%) and more than one
site in 59 patients (59%), at the Parietal in 9 patients (9%) and in 10 patients
(10%) at Occipital and neck.
9. All the 63 patients underwent diagnostic nasal endoscopy out of which  9
patients (28.12%) were found to have mucosal contact points.
10. Out of 9 patients of headache due to mucosal contact points, all 9 underwent
FESS, out of which 8 patients (88.88%) had total relief from headache and 1
patients (11.12%) had significant relief.
11. Out of the remaining 23 patients of headache 21 patients underwent FESS, 7
patients (33.33%) had complete relief from pain, 3 patients (14.29%) had
significant symptom improvement, 11 patients (52.38%) had NO benefit from
surgery. It showed that 67% of patients had improvement of headache after
undergoing FESS.
12. 11 Patients with no relief was clinically examined and consulted with neurologist
and psychiatrist and 6 patients were diagnosed as tension type headache and 5
patients were diagnosed as migraine and they are treated accordingly.
13. Endoscopic management of headache due to sinogenic causes provides a tool to
the surgeon by which he can accurately diagnose meticulously and with minimal
trauma operate and precisely provide postoperative care and follow-up.
CONCLUSION
Headache is nearly a universal human experience. The lifetime
incidence of headache is estimated to be at least 90%.Before treating the headache it
should be known that whether the headache is primary (when no clear pathologic
condition can be identified) or secondary (metabolic, infectious, inflammatory,
traumatic, neoplastic, immunologic, endocrine, vascular).
A carefully taken history is key to accurate diqgnosis that the
majority of patients will not have sinogenic pain. Examination should
include nasal endoscopy, which is particularly useful if the patient is
currently in pain. In such circumstances, a normal nasal endoscopy makes the
diagnosis of Sinogenic pain extremely unlikely.
Sinus x-rays are not helpful in the diagnosis and management of
chronic facial pain and sinusitis. Computed tomography scans should not be
routinely performed because sinus mucosal thickening is common in
asymptomatic patients and management based only on scan findings will result
in unnecessary surgery.
Given that the majority of patients presenting with facial pain will
not have sinusitis, surgery is very rarely indicated in the treatment of chronic
facial pain.
Familiarity with the various medications available to treat
nonsinogenic facial pain and liaison with other specialties, such as neurology,
maxillofacial surgery and clinical psychology will benefit patients.
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PROFORMA
HEADACHE QUESTIONNAIRE
DEPARTMENT OF OTORHINOLARYNGOLOGY
THANJAVUR MEDICAL COLLEGE HOSPITAL,THANJAVUR
NAME-
AGE/SEX-
ADDRESS-
MOBILE NO-
1. Description of Present Illness-
1a. Complaint of  Headache  for
1b. Getting  headaches about every:  day  week  month  three-months  year   (circle 1)
1c. Headaches last:    seconds  minutes    hours  days   (circle 1)
1d.  Description of head pain (circle one or several)
throbbing pulsating constant
tight squeezing sharp            tender
1e: Headaches are located (mark location, one or several)
2.Headache is accompanied by-
Diarrhea
Dizziness
Drooping eye lid
Facial tenderness
Fever
Flushing on one side of the face
Light sensitivity
Loss of consciousness
Nausea or vomiting
Neck stiffness
Noise sensitivity
Numbness in face/arm/leg
Red, tearing eye
Runny nose/congestion
Swelling of ankles
Speech disturbance
Visual disturbances
Weakness in face/arm/leg
3A. Is your head pain triggered by any of the following-
Alcohol
Bending over
Blood Pressure
Depression, anxiety, nerves, or stress
Headmovement
Menstrual periods
Seasons
Swallowing
Sleep or Lack of sleep
3B. Is your head pain relieved by any of the following-
Coldcompresses
Heat
Massage
Medication
Moving around
Relaxation
Sleep
Vomiting
4.Life Style-
How many alcoholic drinks per day ?
How many caffeinated drinks per day ?
How many hours do you sleep per day ?
Do you smoke cigarettes, cigars or pipes ? No Yes
Are you usually highly stressed ? No Yes
Do you usually eat 3 meals/day ? No Yes
5. INJURIES-
head
neck (for example whiplash)
dental work preceding onset of headache ?
6.Current medications include hormones, birth control pills,
vitamins, etc. (Name and amount/day)?
7.FAMILY HISTORY-
Are there any family members with
Diabetes
Stroke
Heart disease or high blood pressure
Migraine headaches
Other diseases that run in the family
8.MEDICAL HISTORY-
9.PREVIOUS STUDIES-
Have you had any of these tests or procedures ?   (circle,
date if done, and please note result if known)
OTHER SPECIALTY VISITS
Opthalmologist
Dentist
Neurologist
NEUROLOGICAL TESTS
Carotid Doppler
Lumbar puncture (spinal fluid examination)
EEG (Brain Wave test for seizures)
GENERAL MEDICAL TESTS
Recent general blood tests (Glucose, blood count)
Heart testing (EKG, Stress test, Holter Monitor)
RADIOLOGY
CT Brain
Sinus X-rays or CT PNS
Neck X-rays, CT or MRI
Chest X-ray
ANNEXURE
ABBREVIATION
1. CTTH -- CHRONIC TENSION TYPE HEADACHE.
2. CDH -- CHRONIC DAILY HEADACHE.
3. IHS -- INTERNATIONAL HEADACHE SOCEITY.
4. ICHD -- INTERNATIONAL CLASSIFICATION OF HEADACHE
DISORDERS.
5. MT -- MIDDLE  TURBINATE.
6. MTH -- MIDDLE  TURBINATE  HYPERTROPHY.
7. UP -- UNCINATE  PROCESS.
8. OMC -- OSTEO  MEATAL  COMPLEX.
9. DNE -- DIAGNOSTIC  NASAL   ENDOSCOPY.
10. CT -- COMPUTERISED  TOMOGRAM.
11. PNS -- PARA  NASAL  SINUS.
12. SMR -- SUB  MUCOSAL  RESECTION.
13. FESS -- FUNCTIONAL  ENDOSCOPIC  SINUS  SURGERY.
 
MASTER CHART 
 
 
S.No NAME/A/S/ADD/IP NO SYMPTOMS ANTERIOR 
AND 
POSTERIOR 
RHINOSCOPY 
DNE CT PNS CT BRAIN DIAGNOSIS TREATMENT OUTCOME 
1 Dhanavally 36 /F 
W/o N. Swaminathan, 1/183, 
VyapuriVaniyar Nagar, 
Thanjavur. 
 
OP :004223 
Pain in forehead 
and cheeks -6 
months 
 
 
DSR, 
Purulent 
secretions + 
DSR RT MAXIILARY 
SINUSITIS 
NORMAL DNS WITH 
SINUSITIS 
SMR WITH 
FESS 
RELIEVED 
2 Kamalaveni 55 /F 
10/67  Dhanalakshminagar 
M C Road,  Manojipatti 
Thanjavur 
 
OP : 002879 
c/o headache    - 
6months 
over both parietal 
regions 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
3 Kalyanasundaram 44/M 
S/o Kasinathan 
Kannur Therkutheruvu 
Needamangalam, 
Kasapaiyanchevadi 
Thanjavur 
OP: 001342 
 
c/o headache  - 4 yrs o  
On & off 
 
DSL, 
Congested 
mucosa 
DSL 
 
LT MAXIILARY 
SINUSITIS 
NORMAL DNS WITH 
SINUSITIS 
SMR WITH 
FESS 
RELIEVED 
4 Jayaraman 45/M 
1/107,Keela main Road, 
Thiruvalansnehi 
c/o headache- 1yr 
 
NORMAL Spur + Normal NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
Kumbakonam. 
OP: 002656 
 
5 Aparna 12/ F 
213, Melalangam, 
ModaamumaarKoil, 
Thanjavur. 
OP: 002462 
c/o headache   - 
2 Months 
 
h/o vomiting 
 
NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
6 Usha 45 /F 
8, Ammankovil street, 
Kumbakonam. 
 
OP: 002458 
C/o headache    - 6 
months 
 
DSL 
 
DSL 
 
DSL NORMAL TENSION 
HEADACHE 
MEDICAL RELIEVED 
`7 Ramadasan 41/ M 
S/o Shanmukham, 
Parathinagar, manojipatti, 
Thanjavur. 
 
OP: 001419 
c/o headache    - 2 
months. 
 
ITH + ITH + NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
8 Thangappan 50 /M 
S/oNatarajan, 
nemam post 
thanjavur dist. 
 
OP: 014592 
c/o   headache   - 5 
months 
h/o nausea 
 
Spur along 
floor 
Spur along 
floor 
NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
9 Sathya 30 /M 
S/o Bhoominathan, 
20A, Vanchur 
Soularjaram, Mannarguditaluk. 
 
OP nos  -  28639 
c/o headache – 5 mon  
vomiting + 
DSR , 
Congested 
mucosa 
DSR  
 
DSR NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
10 Latha 48/ F 
W/o Manivannan, 
106A Thendral Nagar 3rd street, 
Natarajapuram south 
c/o headache   - 2 yr NORMAL 
 
DSL  
 
DSL  NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
colony,Thanjavur. 
OP: 002288 
11 Kayalvizhi 27/F 
398, Periyakottai, 
Mohanir post 
Kantharvakottai. 
 
OP: 003763 
c/o headache  -  
1month 
 
Frontal tenderness 
 DSL 
 
 DSL 
 
DSL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
12 Mani 60 /M 
96, kallukaranpatti 
Valavampatti post 
Pudukkottai 
 
OP: 002896 
c/o headache   - 1yr 
frontal tenderness + 
 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
13 Jennifer 29/ F 
31/71 Mathakoilst, 
Maharajapuram 
Thiruvaiyyar 
 
OP: 003974 
c/o headache – 2mont  
 
spur along  
floor 
 
spur along  
floor 
 
NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
14 Rasathi 44 F 
203, Ayyavadi 
Mathakottai 
Kumbakonam 
 IP: 156211 
c/o  headache  - 
2yrs 
Purulent 
secretions + 
spur along 
floor  
(left) 
Rt maxillary polyp 
with bilateral 
concha bullosa 
NORMAL SINUSITIS 
with POLYP 
SURGIAL SUBJECTIVE 
IMPROVEMENT 
`15 Kamalasanan 55 M 
10/67  Dhanalakshminagar 
M C Road,  manojipatti 
Thanjavur 
 
OP: 002498 
c/o headache - 1 mon  
 
NORMAL spur along 
floor 
NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL RELIEVED 
16 N selvaraj 19 M 
S/o Natarajan 
Alakudi,Melaputturtheru 
c/o  headache   - 4 
yrs 
 
DSL 
 
mild DSL 
 
NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
Thanjavur 
 
OP: 002469 
frontal region 
tenderness+ 
h/o eye pain 
 
17 Bairoja 30 F 
2nd street, rahimnagar 
Mohammed bardar 
Kalyanapuram 
 
OP : 003891 
c/o headache     - 
2yrs 
 
h/o vomiting 
congested 
mucosa 
 
congested 
mucosa 
 
NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
18 Pulavendran 32 M 
175, ilangudu 
Sivan kovilvedakkumpuram 
Thirukkattupalli 
 
OP: 02831 
c/oheadac he   - 3 
yrs 
 
DSL +  
congested 
nasal 
mucosa + 
 
DSL +  
congested 
nasal 
mucosa + 
 
DSL with 
SINUSITIS 
NORMAL DNS with 
SINUSITIS 
SMR WITH 
FESS 
SUBJECTIVE 
IMPROVEMENT 
19 Anbudasan 30 M 
200, Palabanandavanam 
Rukmaniammal madam 
CRC ( Near) 
Thanjavur 
 
OP: 02007 
c/o headache  - 1 
month 
 
no h/o vomiting 
 
SMR done 4 yrs 
back 
NORMAL 
 
spur along 
floor 
 
NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
20 Karigaalan 42 M 
T. Karunanidhi 
3, vadayarpatti 
Margalore post 
Kantharvakottai 
 
OP: 12609 
c/o  headache  -      
1yr 
 
frontal headache 
 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
21 Sakunthala 47 f 
Saranthopputtam 
Keelakabilsthalam 
Papanasam 
 
OP: 28453 
 
c/o  headache   -  
6yrs 
 
C/o  nasal 
obstruction 
DSL 
 
gross 
deviation 
to left 
 
NORMAL  
 
NORMAL TENSION 
HEADACHE 
MEDICAL NOT  IMPROVED 
22 Fathima 25 f 
No 7, Machirastreet 
Pullampadi 
Lalgudi 
 
OP: 03761 
 
c/o headache – 2yrs 
h/o common cold 
on & off 
 
DSL 
congested 
mucosa 
 
DSL 
congested 
mucosa 
 
NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
23 Sivagangai  54f 
c/o B R Ganesan 
thartakalpadugai 
neadamangalam 
 
OP: 02525 
c/o headache -  5 
month 
 
DSL+ 
 
frontal  
tenderness 
DSL+ 
 
frontal  
tenderness 
FRONTAL 
SINUSITIS 
NORMAL DNS with 
SINUSITIS 
SMR WITH 
FESS 
SUBJECTIVE 
IMPROVEMENT 
24 Natesan 44 M 
c/o E V Rajendran 
2/57, common koil street 
Mathur, 
Thanjavur 
 
OP: 03891 
 
c/o  headache  - 1 
wk 
h/o increased 
sneezing 
 
spur along 
floor 
 
spur along 
floor 
 
NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL RELIEVED 
25 Sivan  19 M 
d/oMurugesan 
709/1 Tahikkani 
Vrandhairajankudikadan 
Orthanadu. 
 
OP: 02691 
c/o headache   - 
1month 
h/o nausea       
no h/o blurring of 
vision 
ophthal opinion   -  
RE 
 
NORMAL NORMAL NORMAL NORMAL REFRACTIV
E ERROR 
GLASSES SUBJECTIVE 
IMPROVEMENT 
26 Sakunthala 26 f 
c/okaliyamurthi 
118, kamatchiammankoil 
Karukudi 
Thiruvaiyam 
 
OP: 02569 
c/o pain over  Rt 
side of face  - 1 wk 
 
no h/o nasal 
obstruction 
 
NORMAL NORMAL NORMAL NORMAL TEMPERO 
MANDIBUL
AR JOINT 
ARTHROSES 
MEDICAL NOT IMPROVED 
27 Ramya 18 f c/o headache – 5 NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
4/926, pookollai 
Pillayarpatti, thanjavur 
 
OP: 27114 
yrs 
no h/o nasal 
obstruction 
h/o vomiting 
h/o photophobia 
28 Packiyam 36 f 
w/oraju 
113, adakara street, 
Manambuchevadi, 
Thanjavur 
 
OP: 36542 
c/o headache – 8 
yrs 
 
increased sneezing 
 
tenderness over 
both maxillary 
sinus 
 
DSR, 
Congested 
mucosa, 
secretions 
 
DSR 
 
Bilateral ethmoid & 
maxillary sinusitis 
 
NORMAL DNS With 
SINUSITIS 
SMR WITH 
FESS 
RELIEVED 
29 Lakshmi 42 f  
w/o Chandrasekhar. 
1/11 rajaram street.Karathai 
 
OP: 02689 
c/o headache 10 yrs 
h/o HOH 
no vomiting 
photophobia  + 
 
 NORMAL 
 
NORMAL 
 
NORMAL NORMAL MIGRAINE MEDICAL NOT IMPROVED 
30 Muhammed Latif 56 M 
S/o Abdulazeez 
100, minnagar 
Chidambaram 
 
OP: 2584 
c/o headache   -  5 
months 
no vomiting 
 
DSL, 
Purulent 
secretions 
   
 
DSL 
   
 
bilateral maxillary 
sinusitis 
NORMAL DNS With 
SINUSITIS 
SMR WITH 
FESS 
RELIEVED 
31 Russiar 30 M 
120, vanchur 
Mannargudi. 
 
OP: 52278 
c/o headache   -  6 
months 
h/o nasal 
obstruction 
h/o vomiting 
NORMAL NORMAL Rt maxillary 
sinusitis 
 
NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
32 Podhumponnu 45 f 
185/54 therkuthan 
Pallikondan 
Malaiyakadu post 
Athirampatti. 
 
OP: 3221 
c/o headache  –  
4yrs 
 
h/o vomiting 
h/o neck pain 
DSL 
 
DSL 
 
NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
33 Sankaravel 26 M 
S/o Manoharan 
331/Athoppu street 
Thanjavur. 
 
OP: 01289 
c/o headache – 1yr 
 
h/o pain in occipital 
region. 
No vomiting 
Congested 
mucosa,  
Secretions 
Congested 
mucosa 
Ethmoid & 
sphenoid sinusitis 
 
NORMAL SINUSITIS SMR WITH 
FESS 
SUBJECTIVE 
IMPROVEMENT 
34 Parimala 32 f 
W/o   sakthivel, 
Thiruvonam post. 
Alangudi 
Puthukottai. 
 
OP:2436 
c/o headache – 1 yr 
h/o nasal 
obstruction. 
h/o vomiting 
h/o photophobia 
 
 SMR with FESS 
(18/06/12) 
 
Headache not 
decreased 
 
NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
35 Anandh 49 M 
S/o Marimuthu 
Mariyammankovil 
Thanjavur. 
 
OP: 2169 
c/o headache – 2 
months 
 
no vomiting 
no nasal obstruction 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL NOT IMPROVED 
36 Indiran 27 M 
S/o Shanmughan 
pudhutheram 
madhagaram 
papanasam. 
 
 OP: 2138 
c/o headache – 1yr 
no vomiting 
no nasal obstruction 
 
DSL 
 
DSL 
 
NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
37 Akhil 21 M 
S/o Anand 
Alangdi. 
 
OP: 23143 
c/o headache – 6 
months 
h/o trauma 
 
h/o occipital 
headache 
NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
  
h/o vomiting 
38 Srikumar 35 M 
3/6, pookkara 3rd street 
St. Josephs school 
Thanjavur. 
 
OP:011228 
c/o headache – 1 yr 
no vomiting 
 
NORMAL DSR NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
39 Gayathri 46 f 
1947, Rahmannagar 
Thamaraistreet 
Alpha housing 
Thanjavur. 
 
OP: 12034 
c/o headache – 1 yr 
 
h/o watery 
discharge 
 
Congested 
mucosa, 
secretions 
DSL bilateral maxillary 
sinusitis 
 
Rt concha bullosa 
NORMAL DNS with 
SINUSITIS 
SMR WITH 
FESS 
NOT IMPROVED 
40 Anambudan 31 M 
Mahendran 
Dhanapackiyam colony 
Kumbakonam road 
Needamangalam. 
 
OP: 21301 
c/o headache – 2 yr 
h/o increased 
sneezing 
 
 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
41 Abiram 16 M  
S/o Ravidran 
31/2, salliaman street 
Thanjavur. 
 
OP: 02154 
 
c/o headache  - 2 
yrs 
 
DSR,  
Congested 
mucosa 
DSR bilateral maxillary 
sinusitis 
NORMAL DNS with 
SINUSITIS 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
42 Malarvizhi 25 f 
w/omanimuthu 
7, old nellumandi street, 
North gate 
Thanjavur. 
 
OP: 32167 
h/o headache  - 
5months 
 
h/o  vomiting 
 
h/o  photophobia 
 
septoplasty done 7 
DSL  DSL with 
buckling 
of septum 
NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
yrs back 
 
43 Vinotha 27 f 
d/o sivasankar 
tharjappudayappatti 
kurankulam west 
sakkaraiallai 
thanjavur. 
  
OP: 01342 
c/o headache – 1yr 
h/o eye pain 
ophthal – myopia 
 
NORMAL NORMAL NORMAL NORMAL REFRACTIV
E ERROR 
GLASSES RELIEVED 
44 Lilly 38 f 
w/o arokyadas 
vilvarayampattikeelatheru 
badalur post 
thanjavur 
 
OP: 09261 
c/o headache  - 2 
yrs 
h/o vomiting 
 
h/o pain Lf 
forehead 
 
NORMAL ITH NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
45 Chinna 22 M 
S/o Ganesan 
rajamadaru post 
keelathottam 
west street, Pattukottai 
 
OP: 018865 
c/o headache  - 8 
yrs 
h/o occipital pain 
 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
46 Amrutharajan 44 M 
S/o Ilangovan 
22, vellalaviduth post 
Karbakuditaluk. 
Pudukottai 
 
OP: 01426  
c/o headache  - 2 
yrs 
no vomiting 
h/o blurring of 
vision. 
 
DSL DSL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
47 Shanthanam 38 M 
S/o Subramani 
1604, upparikani 
North street. 
Manojipatti 
 
c/o headache -5 
months 
no vomiting 
no vision problems 
 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
OP: 02651 
 
48 Murugesan 25 M 
3/357, melathelikottai 
West street 
Mannargudi. 
 
OP: 26111 
 
c/o headache  - 5 
months 
 
h/o nausea 
 
NORMAL DSL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
49 Suryan 17 M  
S/o Selvaraj 
south street 
ganapathipuram 
pudukkottai. 
 
OP: 21842 
 
c/o headache -5 
months 
nasal obstruction + 
 
DSR, 
Purulent 
secretions + 
 
 
 
DSR 
 
 
 
bilateral maxillary 
sinusitis 
 
 
NORMAL DNS with 
SINUSITIS 
SMR WITH 
FESS 
SUBJECTIVE 
IMPROVEMENT 
50 Vadivel , 55 M 
55, krishnankoil 2nd street, 
Manamachavadi, Thanjavur 
 
 
OP: 18632 
 
C/o headache – 5 
yrs 
   
frontal tenderness 
+ 
BP : 160/100 mm 
of Hg 
 
NORMAL NORMAL NORMAL NORMAL HYPERTENS
IVE 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
51 Abdulla  44, M 
Rajajinagar, 
Thanjavur. 
 
OP: 27537 
c/o headache – 1 yr 
frontal and occipital 
region 
h/o vomiting 
DSL DSL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL RELIEVED 
52 Mahesh  32 M 
Varappur, perungalur 
Pudukottai 
 
OP: 02781 
c/o – headache – 4 
days 
h/o giddiness 
h/o assault – 2yrs  
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL NOT IMPROVED 
53 Gunasekaran 43 M 
OP : 004787 
c/o headache – 1 yr 
frontal region 
ITH both 
sides, 
septum 
midline 
FRONTAL & 
MAXILLARY 
NORMAL FRONTOMA
XILLARY 
FESS SUBJECTIVE 
IMPROVEMENT 
Umayalpuram, 
Attrankamaistreet, 
Indira nagar. 
 
OP: 03122 
 
h/o sneezing 
 
congested 
mucosa 
 
ITH both 
sides, 
congested 
mucosa 
 
SINUSITIS SINUSITIS 
54 Mahadevaiya  30 M 
Cheyyamangalam, 
Thiruvaiyam. 
 
OP : 23137 
c/o headache – 1 
month 
frontal region 
h/o  sneezing, nasal 
obstruction 
 
DSL , 
congested 
mucosa 
 
DSL , 
congested 
mucosa 
 
NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
55 Anjalai 60 F 
Chintaani, thanjavur. 
 
OP : 324887 
c/o headache – 1 yr 
frontal region 
no h/o 
sneezing,vomiting 
 
DSL DSL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL NOT IMPROVED 
56 Lakshmi 30 f 
Chennampatti, vallom 
 
OP : 10594 
 
c/o headache – 1 
month 
h/o pain forehead 
h/o flashes of light 
 
NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
57 Selvan  28 M 
Manjanarikothai, Thanjavur. 
 
OP: 36128 
c/o headache -  3 
wks 
Rt side of forehead 
NORMAL NORMAL NORMAL NORMAL CLUSTER 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
58 Suresh 27 M     
Thiruvenganuoor,  
Thanjavur 
 
OP: 03448 
 
c/o headache – 6 
yrs 
parietal& temporal 
region 
no vomiting 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
59 Vivek 20 M 
Ammanpettai, thanjavur. 
 
 
c/o headache  -  6 
yrs 
frontal region 
no h/o nasal 
obstruction 
DSL, 
secretions 
DSL SINUSITIS NORMAL DNS with 
SINUSITIS 
SMR WITH 
FESS 
RELIEVED 
OP: 14321 h/o common cold 
on & off 
60 Baby  54  M 
Anjanakovil street 
Thanjavur 
 
OP: 29031 
 
c/o headache – 1 
month 
h/o nasal 
obstruction  Left 
side 
DSR DSR DSR NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
61 Rajaseswari  24 F 
Thanjavur 
 
OP : 023738 
c/o headache -  15 
days 
 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
62 Aswathy 10 F 
Manojipatti. 
Thanjavur 
 
 
 
OP: 13201 
c/o headache – 2 
months 
frontal tenderness 
 
both tonsils 
enlarged. Both JD 
nodes enlarged 
diagnosis – frontal 
DSL, 
secretions+ 
DSL, 
adenoid 
hypertroph
y 
DSL, SINUSITIS NORMAL DNS with 
SINUSITIS 
with 
CHRONIC  
ADENO 
TONSILLITIS 
SMR WITH 
FESS 
RELIEVED 
63 Shinose 17 M 
Peravur, 
Vallom  
 
OP: 01273 
c/o headache – 2 
months 
 
vomiting , 
giddiness 
 
NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
64 Valli  48 F 
Thirakkattupalli. 
Thanjavur 
 
OP : 26235 
 
c/o headache  - 2 
months 
Reddening of eyes 
 
NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
65 Raju  49 M 
south street, Easwarankoil 
bath, 
Senthalai,  Nadukavery, 
thiruvayur 
c/o headache 3 yrs 
parietal region 
 
h/o dizziness 
 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL NOT IMPROVED 
 
OP: 305470 
 
66 Sharmila 22 f 
c/ochinanniyan, Thirunaippu, 
Poondi, Papanasam, 
Thanjavur. 
 
OP: 20071 
 
 
c/o headache  - 1yr 
occipital region 
h/o  vomiting, light 
sensitivity, visual 
disturbances 
pain increased 
during menstrual 
periods 
 
NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
67 Umesh 26 M 
527, Anna nagar, 
Tholagripatti, Kurungulam, 
Thanjavur 
 
OP: 05966 
 
c/o headache  - 1 yr 
h/o runny nose 
triggered by 
seasonal changes 
 
DNS, 
Congested 
mucosa 
DNS, 
Congested 
mucosa 
SINUSITIS NORMAL DNS with 
SINUSITIS 
SMR WITH 
FESS 
RELIEVED 
68 Durai   24 M 
Parukaividudi, Mohanur post, 
gandharvakottai 
Pudukottai 
 
OP:31650 
c/o headache 3 
months 
retro orbital 
 
NORMAL NORMAL NORMAL NORMAL CLUSTER 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
69 Govindaraj  50 M 
Puliyakoodi, Vadakithoppu 
 
OP:05246 
 
C/o headache – 
2months 
parietal region 
 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
70 Selvi 35 F 
3rd street, Rajagopalapuram, 
Pudukottai 
 
OP: 034178 
c/o headache  - 3yrs 
 
h/o running nose 
left side 
 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
71 Kannusami  28 M 
nos 5, Sreekrishna Nagar 
manojipatti . 
 
OP: 02235 
 
c/o headache – 4yrs 
triggered with 
depression, anxiety 
 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
72 Sangeetha 25 F 
vandayariruppu 
orathanadu 
 
OP:17106 
 
c/o headache – 3 
months 
h/o nausea, runny 
nose 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL RELIEVED 
73 Vidya 33 F 
Vedapuram, Aadichapuram 
Mannargudi, Thiruvarur 
 
OP:24359 
 
 
c/o headache – 3 
yrs 
h/o nausea, noise 
sensitivity, red 
tearing eyes, runny 
nose 
triggered by lack of 
sleep 
NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
74 Amudha 38 F 
Ayyampettaibypassroad, 
Papanasam,thanjavur 
 
OP:01419 
 
 
c/o headache – 1 
year 
h/o noise 
sensitivity, red 
tearing eyes 
 
triggered by 
bending over, head 
movements 
 
ophthal opinion – 
Normal 
NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
75 Guhe 48 F 
Melapuliyampettai, 
Ambedkarnagar, 
Thirubhuvanam post,  
c/o  headache – 3 
months 
h/o dizziness,  
visual disturbance 
 
NORMAL NORMAL NORMAL NORMAL HYPERTENS
ION 
MEDICAL RELIEVED 
 OP: 012673 
recent onset  
hypertension 
 
76 Manoj 14 M 
poondi,kunnalkudi post, 
Thanjavur. 
 
OP:56910 
 
 
c/o headache – 1 
yrs 
retro orbital region, 
neck pain 
h/o dizziness 
 
Ophthal opinion – 
adviced glasses for 
past 3 yrs 
NORMAL NORMAL NORMAL NORMAL REFRACTIV
E ERROR 
GLASSES RELIEVED 
77 Palanivel  40  M 
vadakkutheru, thalapatti, 
rasuwapath, Vallam 
 
OP: 74978 
 
c/o headache 10 yrs 
parietal area 
h/o dizziness, facial 
tenderness, nausea, 
neck stiffness 
 
h/o accidental fall 5 
yrs back 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
78 Saraswathy  30 F 
s/oselvaraj, Pillayarkovil 
street, Anthali 
Naducauvery ,Thanjavur 
Mob – 9659642074 
 
OP: 002999 
C/O headache 1 yr 
area 
 
 
DSL, 
Secretions 
DSL OMC Crowding, 
Concha Bullosa 
NORMAL DNS with 
SINUSITIS 
SMR WITH 
FESS 
SUBJECTIVE 
IMPROVEMENT 
79 Vijay 38 M 
S/O Manikkam, 
Kallukarampatti,  
Perungalur, Thanjavur 
 
OP:  013799 
c/o headache – 9 
months 
 
triggered by 
bending over, head 
movements 
 
NORMAL NORMAL NORMAL NORMAL TRIGEMINAL 
NEURALGIA 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
80 Devidasan  30 M 
200, Palabanandavanam 
Rukmaniammal madam 
c/o headache – 1 yr 
frontal and occipital 
region 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL NOT IMPROVED 
CRC ( Near) 
Thanjavur 
  
OP: 023841 
81 Amrutharani 34 F 
W/o Ilangovan 
22, vellalaviduth post 
Karbakuditaluk. 
Pudukottai 
 
OP: 03192 
c/o headache  - 2 
yrs 
vomiting 
h/o blurring of 
vision 
DSL DSL NO SINUSITIS NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
82 Lakshmanan 39 M 
256/12 
Chennampatti, vallom 
 
OP : 17694 
 
c/o headache – 1 
yrs 
h/o pain forehead 
more at morning 
 
chronic alcoholic 
NORMAL NORMAL NORMAL NORMAL ALCOHOLIC MEDICAL RELIEVED 
83 Selvanath   55 M 
Manjanarikothai, Thanjavur. 
 
OP: 23410 
c/o headache -  3 
wks 
h/o nasal 
obstruction 
DSL, 
congested 
nasal 
mucosa 
 
DSL, 
congested 
nasal 
mucosa 
 
DSL , SINUSITIS NORMAL DNS with 
SINUSITIS 
SMR WITH 
FESS 
NOT IMPROVED 
84 Lalitha 32 f 
Karunayapattom 
3, vadallore 
Margalore post 
Kantharvakottai 
OP:06845 
c/o  headache  -      
1yr 
 
frontal headache 
 
NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
85 Avinash   30, M 
Rajajinagar, 
Thanjavur. 
 
OP: 046732 
c/o headache – 1 yr 
frontal and occipital 
region 
h/o vomiting 
 
 
NORMAL DSL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
86 Lakshmi 32 F 
Varappur, perungalur 
Pudukottai 
c/o – headache – 4 
days 
h/o giddiness 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
 
OP: 033221 
h/o assault – 2yrs 
back (over parietal 
region) 
 
87 Silambuselvi 39 F 
w/o kamaraj 
Alakudi,Melaputturtheru 
Thanjavur 
 
OP:  021784 
 
c/o  headache   - 4 
yrs 
 
frontal region 
tenderness+ 
h/o eye pain 
 
DSL 
 
mild DSL 
 
NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
88 Salaam 36 M 
2nd street, rahimnagar 
Mohammed bardar 
Kalyanapuram 
 
OP: 017962 
c/o headache     - 
2yrs 
 
h/o vomiting 
NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
89 Vasantha 32 f  
175, idavallore 
kolippatti 
Thirukkattupalli 
 
OP:023671 
c/oheadache   - 3 
yrs 
 
DSL 
congested 
nasal 
mucosa + 
 
DSL 
congested 
nasal 
mucosa + 
 
DSL with 
SINUSITIS 
NORMAL DNS with 
SINUSITIS 
SMR WITH 
FESS 
RELIEVED 
90 Vijayadarsini   19 f 
d/o sundaram  
709/1 Tahikkani 
Vrandhakudikadan 
Orthanadu. 
  
OP: 129071 
c/o headache   - 
1month 
h/o nausea       
 
 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
91 Saravanan 44 M 
118,ammankoil 
Karukudi 
Thiruvaiyam 
 
OP: 028952 
c/o pain over Rt 
side of face  - 1 
month 
 
no h/o nasal 
obstruction 
 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
92 Puneethavally  38 F 
4/926,  south pookollai 
Medical college, thanjavur 
 
OP: 031456 
c/o headache – 5 
yrs 
no h/o nasal 
obstruction 
h/o vomiting 
h/o photophobia 
 
NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL NOT IMPROVED 
93 Keerthiga  25 f 
No 7,veera nagar street 
Pillayarpetti 
thanjavur 
 
OP: 002389 
c/o headache – 2yrs 
h/o common cold 
on & off 
 
DSL 
congested 
mucosa 
 
DSL 
congested 
mucosa 
 
DSL with 
SINUSITIS 
NORMAL DNS with 
SINUSITIS 
SMR WITH 
FESS 
RELIEVED 
94 Saroja  35 f 
185/54 therkuthan 
Pallikondan 
Malaiyakadu post 
Athirampatti. 
 
OP: 038511 
c/o headache  –  
4yrs 
 
h/o neck pain 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
95 Aakash  26 M 
S/o Sami 
331/Athoppu street 
Thanjavur. 
 
OP: 087201 
c/o headache – 1yr 
 
h/o  nose block 
h/o cold on & off 
DSL, 
Secretions 
DSL SINUSITIS NORMAL DNS with 
SINUSITIS 
SMR WITH 
FESS 
RELIEVED 
96 Pakkeerisami 32 M 
S/o   sakthivel, 
Alangudi 
Puthukottai. 
 
OP: 12672 
 
 
c/o headache – 1 yr 
h/o nasal 
obstruction. 
h/o vomiting 
h/o photophobia 
NORMAL NORMAL NORMAL NORMAL MIGRAINE MEDICAL SUBJECTIVE 
IMPROVEMENT 
97 Senthil  30 M 
Cheyyamangalam, 
Thiruvaiyam. 
c/o headache – 1 
month 
frontal region 
DSL, 
Congested 
mucosa 
DSL SINUSITIS NORMAL DNS with 
SINUSITIS 
SMR WITH 
FESS 
SUBJECTIVE 
IMPROVEMENT 
 
OP : 23137 
h/o  sneezing, nasal 
obstruction 
 
98 Abishek   30, M 
Municipal colony, 
Thanjavur. 
 
OP: 013623 
 
c/o headache – 1 yr 
frontal and occipital 
region 
h/o vomiting 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL RELIEVED 
99 Sebastian 32 M 
perungalur 
Pudukottai 
 
OP: 063012 
c/o – headache – 2 
yrs 
h/o giddiness 
h/o assault – 2yrs 
back (over parietal 
region) 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
100 Tamilselvi  20/ F 
Ammanpettai, thanjavur. 
 
OP: 073673 
c/o headache  -  1 yr 
frontal region 
no h/o nasal 
obstruction 
h/o common cold 
on & off 
 
NORMAL NORMAL NORMAL NORMAL TENSION 
HEADACHE 
MEDICAL SUBJECTIVE 
IMPROVEMENT 
 
